<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Mar Drugs</journal-id><journal-id journal-id-type="iso-abbrev">Mar Drugs</journal-id><journal-id journal-id-type="publisher-id">marinedrugs</journal-id><journal-title-group><journal-title>Marine Drugs</journal-title></journal-title-group><issn pub-type="epub">1660-3397</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">9225448</article-id><article-id pub-id-type="doi">10.3390/md20060341</article-id><article-id pub-id-type="publisher-id">marinedrugs-20-00341</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Recent Advances in the Heterologous Expression of Biosynthetic Gene Clusters for Marine Natural Products</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Yushan</given-names></name><xref rid="af1-marinedrugs-20-00341" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Du</surname><given-names>Xinhua</given-names></name><xref rid="af1-marinedrugs-20-00341" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Xionghui</given-names></name><xref rid="af1-marinedrugs-20-00341" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Qian</given-names></name><xref rid="af1-marinedrugs-20-00341" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Kaiwen</given-names></name><xref rid="af1-marinedrugs-20-00341" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9793-0674</contrib-id><name><surname>Xu</surname><given-names>Jinzhong</given-names></name><xref rid="af1-marinedrugs-20-00341" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2960-8573</contrib-id><name><surname>Wang</surname><given-names>Pinmei</given-names></name><xref rid="af1-marinedrugs-20-00341" ref-type="aff">1</xref><xref rid="af2-marinedrugs-20-00341" ref-type="aff">2</xref><xref rid="c1-marinedrugs-20-00341" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Ivanchina</surname><given-names>Natalia V.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-marinedrugs-20-00341"><label>1</label>Ocean College, Zhejiang University, Zhoushan 316021, China; <email>xuyushan@zju.edu.cn</email> (Y.X.); <email>duxinhua@zju.edu.cn</email> (X.D.); <email>xiaohuige@zju.edu.cn</email> (X.Y.); <email>jiangqian11@zju.edu.cn</email> (Q.J.); <email>kevin_zhengplus@zju.edu.cn</email> (K.Z.); <email>xujinzhong@zju.edu.cn</email> (J.X.)</aff><aff id="af2-marinedrugs-20-00341"><label>2</label>State Key Laboratory of Motor Vehicle Biofuel Technology, Zhejiang University, Zhoushan 316021, China</aff><author-notes><corresp id="c1-marinedrugs-20-00341"><label>*</label>Correspondence: <email>wangpinmei@zju.edu.cn</email></corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>5</month><year>2022</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2022</year></pub-date><volume>20</volume><issue>6</issue><elocation-id>341</elocation-id><history><date date-type="received"><day>20</day><month>4</month><year>2022</year></date><date date-type="accepted"><day>20</day><month>5</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; 2022 by the authors.</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Marine natural products (MNPs) are an important source of biologically active metabolites, particularly for therapeutic agent development after terrestrial plants and nonmarine microorganisms. Sequencing technologies have revealed that the number of biosynthetic gene clusters (BGCs) in marine microorganisms and the marine environment is much higher than expected. Unfortunately, the majority of them are silent or only weakly expressed under traditional laboratory culture conditions. Furthermore, the large proportion of marine microorganisms are either uncultivable or cannot be genetically manipulated. Efficient heterologous expression systems can activate cryptic BGCs and increase target compound yield, allowing researchers to explore more unknown MNPs. When developing heterologous expression of MNPs, it is critical to consider heterologous host selection as well as genetic manipulations for BGCs. In this review, we summarize current progress on the heterologous expression of MNPs as a reference for future research.</p></abstract><kwd-group><kwd>marine natural products</kwd><kwd>heterologous expression</kwd><kwd>heterologous hosts</kwd><kwd>biosynthetic gene clusters</kwd><kwd>genetic manipulation</kwd></kwd-group><funding-group><award-group><funding-source>Zhoushan City-Zhejiang University Joint Specific Project</funding-source><award-id>2020C81004</award-id></award-group><award-group><funding-source>Hainan Provincial Natural Science Foundation of China</funding-source><award-id>321QN273</award-id></award-group><funding-statement>This research was funded by the Zhoushan City-Zhejiang University Joint Specific Project (grant number 2020C81004) and Hainan Provincial Natural Science Foundation of China (grant number 321QN273).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-marinedrugs-20-00341"><title>1. Introduction</title><p>Oceans cover 71% of the Earth&#x02019;s surface and approximately 87% of the biosphere, and possess specific pH, temperature, pressure, oxygen content, light, and salinity greatly different from the land [<xref rid="B1-marinedrugs-20-00341" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-20-00341" ref-type="bibr">2</xref>]. With the development of deep-sea exploration technology, spectroscopy, X-ray crystallography, and various separation techniques, marine natural products (MNPs) have attracted widespread concerns [<xref rid="B3-marinedrugs-20-00341" ref-type="bibr">3</xref>]. The complexity and the multidomain of the chemical structures endow many MNPs with specific bioactivity, allowing them to be the ideal candidates for new drug development. Secondary metabolites (SMs) of marine microorganisms have pharmaceutical value [<xref rid="B4-marinedrugs-20-00341" ref-type="bibr">4</xref>]. Marine microorganisms inhabit almost all ecological niches that are available, and those who survive in harsh conditions secrete SMs with novel chemical structures and unique physiological properties [<xref rid="B2-marinedrugs-20-00341" ref-type="bibr">2</xref>,<xref rid="B5-marinedrugs-20-00341" ref-type="bibr">5</xref>]. From 2018 to 2020, over 40 bioactive compounds derived from marine microorganisms were reported, and they were compiled in Ameen&#x02019;s review [<xref rid="B4-marinedrugs-20-00341" ref-type="bibr">4</xref>]. Notably, in 2018, brentuximab vedotin derived from cyanobacteria <italic toggle="yes">Symploca</italic> sp. was approved by the United States Food and Drug Administration (US FDA) to treat Hodgkin&#x02019;s lymphoma cancer (<uri xlink:href="https://www.fda.gov/drugs/resources-information-approved-drugs/brentuximab-vedotin">https://www.fda.gov/drugs/resources-information-approved-drugs/brentuximab-vedotin</uri>, accessed on 19 April 2022). However, research on the biodiversity of marine microorganisms and the bioactivity of their metabolites is still very limited, since only 0.1% of marine microorganisms have been explored or even less than 0.01% [<xref rid="B6-marinedrugs-20-00341" ref-type="bibr">6</xref>,<xref rid="B7-marinedrugs-20-00341" ref-type="bibr">7</xref>]. Furthermore, epifluorescence microscopy and rRNA sequencing for microbial community analysis have revealed that microbes that can be cultured in laboratory represent only a small fraction of the microbial community, and in most cases, are not the dominant population under natural conditions [<xref rid="B8-marinedrugs-20-00341" ref-type="bibr">8</xref>]. At the same time, due to the extremely low reproducibility and the small amounts of activated compounds extracted from marine microbial samples, it is difficult to obtain sufficient MNPs for the further analysis of biological activities and medicinal properties. In addition, total chemical synthesis is hard to realize economically, especially for the MNPs with complex structures [<xref rid="B9-marinedrugs-20-00341" ref-type="bibr">9</xref>], which also hinders the subsequent studies such as the verification and optimization of drug structures.</p><p>Marine microorganisms aggregate and sequentially arrange the genes involved in the biosynthesis of a certain MNP as biosynthetic gene clusters (BGCs) [<xref rid="B10-marinedrugs-20-00341" ref-type="bibr">10</xref>,<xref rid="B11-marinedrugs-20-00341" ref-type="bibr">11</xref>]. Today, high-throughput DNA sequencing technologies coupled with convenient genome mining and metabolomic analysis tools allow researchers to rapidly identify BGCs in microbial genomes [<xref rid="B12-marinedrugs-20-00341" ref-type="bibr">12</xref>]. This technical breakthrough provides new avenues for the mining, modification, and production of MNPs. On the basis of genomics, we can subsequently use molecular techniques to biosynthesize high titers of MNPs, rather than merely using traditional separation and purification techniques to obtain small amounts of chemical compounds [<xref rid="B13-marinedrugs-20-00341" ref-type="bibr">13</xref>]. Genome mining is used to speculate the potential functions of the metabolites guided by BGCs [<xref rid="B14-marinedrugs-20-00341" ref-type="bibr">14</xref>,<xref rid="B15-marinedrugs-20-00341" ref-type="bibr">15</xref>]. Modern bioinformatic and genetic tools can also efficiently eliminate known metabolites from complex metabolite mixtures, increasing the rate of discovery of new products [<xref rid="B16-marinedrugs-20-00341" ref-type="bibr">16</xref>]. For example, the most widely used bioinformatics tool, antiSMASH [<xref rid="B17-marinedrugs-20-00341" ref-type="bibr">17</xref>], can provide detailed information about BGCs and output the stereochemical data about the assumptive compound and the amino acid module that builds the compound. Specifically, an open access database designed for MNPs called CMNPD (comprehensive marine natural products database) [<xref rid="B18-marinedrugs-20-00341" ref-type="bibr">18</xref>] has been available for researchers to determine the accurate chemical structures of MNPs and assist in calculating their physicochemical and pharmacokinetic properties. More bioinformatics tools and databases for the genome mining of MNPs are included in Ambrosino&#x02019;s review [<xref rid="B19-marinedrugs-20-00341" ref-type="bibr">19</xref>].</p><p>A major challenge to biosynthesize MNPs is the low expression or silence of MNP BGCs in laboratory. Researchers have developed several triggering strategies to activate cryptic BGCs. For culturable strains, the one strain many compounds (OSMAC) strategy excavates the potential of a specific microorganism to produce different natural products (NPs) by systematically varying culture parameters including medium composition, aeration rate, culture vessel, and the addition of enzyme inhibitors [<xref rid="B20-marinedrugs-20-00341" ref-type="bibr">20</xref>]. Moreover, screening strains with mutations in RNA polymerase or ribosomal proteins, as well as the deletion or induction of global transcriptional regulators, are genetic engineering techniques that have successfully triggered the expression of cryptic BGCs in microorganisms [<xref rid="B11-marinedrugs-20-00341" ref-type="bibr">11</xref>]. In addition, epigenetic regulation and chromatin-level remodeling approaches can precisely control the homologous or heterologous expression of BGCs by expressing pathway-specific activation genes or deleting pathway-specific repressor genes. Likewise, strong promoters can be added to BGCs to stimulate strains to produce specific SMs [<xref rid="B21-marinedrugs-20-00341" ref-type="bibr">21</xref>,<xref rid="B22-marinedrugs-20-00341" ref-type="bibr">22</xref>,<xref rid="B23-marinedrugs-20-00341" ref-type="bibr">23</xref>]. More concrete BGCs awakening strategies are summarized in Choi&#x02019;s review [<xref rid="B24-marinedrugs-20-00341" ref-type="bibr">24</xref>].</p><p>However, these strategies are not amenable for all BGCs of MNPs. Above all, studies have shown that a large proportion of marine microorganisms are not culturable, which impedes the extraction and identification of bioactive metabolites from them. So apparently, the OSMAC strategy does not work in unculturable strains, and this strategy requires a relatively large experimental volume for strains with low production of MNPs. In addition, the supplementation of the medium with chromatin modifiers (such as histone deacetylase inhibitors) is not able to activate the cryptic BGCs in all species of fungi [<xref rid="B25-marinedrugs-20-00341" ref-type="bibr">25</xref>]. Furthermore, for the majority of BGCs, the external and/or internal signals that trigger their expression remain unknown. Even for the culturable marine microorganisms, they are inclined to show a small metabolic profile under the traditional conditions in laboratory. Otherwise, other strategies such as cocultivation and mixed fermentation should be considered to stimulate the production [<xref rid="B26-marinedrugs-20-00341" ref-type="bibr">26</xref>]. Moreover, a low metabolic rate and complex metabolic background may also lead to missed metabolites. To overcome these challenges, expressing BGCs in a heterologous host with a clear background of metabolites to obtain MNPs of high quality and quantity becomes a reliable alternative.</p><p>The expression of BGCs cloned from uncultured species and environment samples is expected to facilitate the discovery of new products and produce valuable compounds [<xref rid="B27-marinedrugs-20-00341" ref-type="bibr">27</xref>,<xref rid="B28-marinedrugs-20-00341" ref-type="bibr">28</xref>,<xref rid="B29-marinedrugs-20-00341" ref-type="bibr">29</xref>]. A heterologous expression platform for marine microorganisms and marine environment samples in the engineered chassis strains provides a feasible method for the efficient production of MNPs, especially for the exploration of fungal MNPs. Fungi can produce a large number of bioactive metabolites [<xref rid="B30-marinedrugs-20-00341" ref-type="bibr">30</xref>], but due to the lack of mature fermentation technology and genetic manipulation tools, fungal MNPs rely heavily on a universal heterologous expression platform. The heterologous expression of terrestrial fungal NPs has made some progress, but most of the heterologous expression of MNPs is still focused on marine bacteria. The heterologous expression of MNPs has the following four advantages. First, a successful heterologous expression allows the correct DNA ligation and efficient co-work of all essential gene fragments in BGCs which indicate the biosynthesis of MNPs. Second, heterologous expression can biosynthesize MNPs from unculturable marine microorganisms and environment samples. Third, heterologous expression relies on a suitable host, reducing the burden of developing novel genetic tools for different strains. Fourth, the library of biosynthetic genes can be continuously updated and optimized, not only for heterologous expression, but also for the genetic manipulation of cloned pathways, biosynthetic studies, or gene remodeling of BGCs [<xref rid="B10-marinedrugs-20-00341" ref-type="bibr">10</xref>]. So far, the heterologous expression of MNPs has made several remarkable advances in expressing BGCs from marine actinomycetes [<xref rid="B31-marinedrugs-20-00341" ref-type="bibr">31</xref>] and cyanobacteria [<xref rid="B32-marinedrugs-20-00341" ref-type="bibr">32</xref>], which exhibits promising prospects for extending this strategy into more marine microorganisms. Efficient heterologous expression first requires the selection and optimization of a suitable heterologous host. Next, the selected BGCs are cloned, assembled into dedicated vectors, and then transferred to heterologous chassis strains for expression. In the end, using methods such as metabolic engineering can mass-produce specific MNPs for clinical research and therapeutic use [<xref rid="B10-marinedrugs-20-00341" ref-type="bibr">10</xref>,<xref rid="B21-marinedrugs-20-00341" ref-type="bibr">21</xref>,<xref rid="B33-marinedrugs-20-00341" ref-type="bibr">33</xref>]. Metagenomics shows an extraordinary potential in the heterologous expression of BGCs for MNPs (<xref rid="marinedrugs-20-00341-f001" ref-type="fig">Figure 1</xref>), since this strategy directly extracts the total community DNA from marine samples without the need for the isolation or culture of microbes [<xref rid="B34-marinedrugs-20-00341" ref-type="bibr">34</xref>]. The combination of metagenomics and efficient bioactivity screening has become an effective method to identify novel bioactivities from inseparable marine microorganisms [<xref rid="B6-marinedrugs-20-00341" ref-type="bibr">6</xref>,<xref rid="B12-marinedrugs-20-00341" ref-type="bibr">12</xref>]. A marine metagenomic library was constructed from tidal flat sediments by Fujita et al. [<xref rid="B27-marinedrugs-20-00341" ref-type="bibr">27</xref>]. Through a metal-binding compound detection test, the researchers relied on the metal ion indicator chrome azurol S (CAS) for functional screening. The siderophore BGC was then cloned and vibrioferrin was heterologously expressed in <italic toggle="yes">Escherichia coli</italic>.</p><p>In this article, we review the research progress on the heterologous expression of MNPs. The heterologous expression of MNPs can be roughly summarized into two main steps: (1) appropriate selections of the heterologous hosts; (2) genetic manipulations for BGCs. These steps exert profound impacts on the effects of heterologous expression. It is clear that the intactness and arrangement of BGCs determine the expression at the genetic level, while the cloning of BGCs usually larger than 10 kb is not so simple. Meanwhile, the endogenous metabolic pathways of the hosts can affect the structures of MNPs, and the mechanisms are difficult to demonstrate and vary from host to host. For example, one research group cloned <italic toggle="yes">ber</italic> BGC, which indicated the formation of berninamycins A and B, while they finally obtained berninamycins J and K in another host, which pointed to the unknown host-dependent enzymes in the host [<xref rid="B35-marinedrugs-20-00341" ref-type="bibr">35</xref>]. Considering the above problems, this review focuses on these two steps, as well as advances in the heterologous expression of MNPs from marine BGCs, which can provide a reference for new MNPs exploration.</p></sec><sec id="sec2-marinedrugs-20-00341"><title>2. Heterologous Hosts for MNPs</title><p>The regulatory factors of heterologous hosts and/or biosynthetic factors control the heterologous expression of NPs [<xref rid="B36-marinedrugs-20-00341" ref-type="bibr">36</xref>]. When selecting the heterologous hosts, the characters of BGCs must be considered, including the required substrates, as well as the genetic and physiological properties of the original strains. In general, the closer the host is to the original strain, the more likely the transcription factors (such as regulatory factors, promoters, and ribosomal binding sites) of exogenous BGCs in hosts will work [<xref rid="B37-marinedrugs-20-00341" ref-type="bibr">37</xref>,<xref rid="B38-marinedrugs-20-00341" ref-type="bibr">38</xref>], due to the similar codon usage patterns shared by the evolutionarily closed strains and therefore, the higher translation efficiency. Each amino acid can be encoded by different synonymous codons whose frequencies vary with different species and the synonymous codon replacement in heterologous hosts would influence the secondary and tertiary protein structures [<xref rid="B39-marinedrugs-20-00341" ref-type="bibr">39</xref>]. Moreover, in closely related heterologous hosts, the exchange of promoters can improve the level of expression and thus increase the yield of target compound [<xref rid="B40-marinedrugs-20-00341" ref-type="bibr">40</xref>]. Some model strains have been modified to adapt to heterologous expression by eliminating the BGCs of their own metabolites. Heterologous hosts are categorized into four groups in <xref rid="marinedrugs-20-00341-t001" ref-type="table">Table 1</xref>. <italic toggle="yes">Streptomyces</italic> are the major force for Gram-positive bacteria and the model strains in <italic toggle="yes">Streptomyces</italic> play an outstanding role in the biosynthesis of antimicrobial agents derived from actinomycetes. Gram-negative bacteria mainly include <italic toggle="yes">E. coli</italic> and cyanobacteria. <italic toggle="yes">E. coli</italic> is an ideal heterologous host for bacterial BGCs, since <italic toggle="yes">E. coli</italic> is a well-developed model species. The model strains of cyanobacteria are also robust hosts for the bacterial BGCs of MNPs, particularly for the medicinal agents from all kinds of cyanobacteria. Other two types of heterologous hosts for MNP BGCs include <italic toggle="yes">Aspergillus</italic> that assists in expressing fungal MNP BGCs and microalgae <italic toggle="yes">Fistulifera solaris</italic> for algal BGCs. Different heterologous hosts for the expression of MNP BGCs are summarized and categorized in <xref rid="marinedrugs-20-00341-t001" ref-type="table">Table 1</xref>.</p><sec id="sec2dot1-marinedrugs-20-00341"><title>2.1. Escherichia. coli</title><p><italic toggle="yes">E. coli</italic> not only grows quickly, but also lacks endogenous secondary metabolic pathways and thus has little background interference from metabolites. At the same time, abundant multifunctional gene manipulation tools can be implemented in <italic toggle="yes">E. coli</italic>. To make <italic toggle="yes">E. coli</italic> compatible with more BGCs from different sources, researchers need to recode the target BGCs by replacing the native codons with synonymous codons frequently used in <italic toggle="yes">E. coli</italic> to eliminate the codon bias between the native strains and hosts [<xref rid="B84-marinedrugs-20-00341" ref-type="bibr">84</xref>]. <italic toggle="yes">E. coli</italic> has been successfully applied to elucidate the enzymatic machinery of multiple biosynthetic pathways and has provided a good platform for the heterologous expression of bacterial and fungal NPs [<xref rid="B85-marinedrugs-20-00341" ref-type="bibr">85</xref>,<xref rid="B86-marinedrugs-20-00341" ref-type="bibr">86</xref>]. Almost all types of NPs can attempt to be produced in <italic toggle="yes">E. coli</italic>, including macrolides, cyclic peptides, terpenes, and alkaloids [<xref rid="B87-marinedrugs-20-00341" ref-type="bibr">87</xref>]. In 2005, two research groups [<xref rid="B60-marinedrugs-20-00341" ref-type="bibr">60</xref>,<xref rid="B88-marinedrugs-20-00341" ref-type="bibr">88</xref>] completed the first genetics-based identification, transfer, and heterologous expression of the biosynthetic pathways from marine microbial symbionts. Researchers cloned and expressed the cyanobacterial symbiont <italic toggle="yes">Prochloron</italic> spp. DNA in <italic toggle="yes">E. coli</italic>, and successfully synthesized the metabolite patellamide with antitumor activity. Since the ocean has a special environment of high salinity, the marine halophilic bacteria become good biological sources for salinity-tolerant enzymes. Yu et al. [<xref rid="B61-marinedrugs-20-00341" ref-type="bibr">61</xref>] cloned a BGC of multidomain &#x003b2;-1,4-endoxylanase with a high molecular weight, <italic toggle="yes">xylM<sub>18</sub></italic> from the halophilic marine bacterium <italic toggle="yes">Marinimicrobium</italic> sp. LS-A18 into the <italic toggle="yes">pET28a</italic> vector and heterologously expressed it in <italic toggle="yes">E. coli</italic> BL21 (DE3). The purified &#x003b2;-1,4-endoxylanase XylM<sub>18</sub> has high activity between pH 6.0~10.0, and the best activity appears at pH 7.0. Its preferable activity is within the range of NaCl 0.2~25% (<italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>), making XylM<sub>18</sub> a suitable candidate enzyme for the biodegradation of xylan under high salt and alkali conditions. However, <italic toggle="yes">E. coli</italic> often cannot efficiently complete the functional folding of key fungal biosynthetic enzymes such as the P450 family enzymes when constructing the entire biosynthetic pathway rather than just expressing core enzymes [<xref rid="B21-marinedrugs-20-00341" ref-type="bibr">21</xref>]. Moreover, <italic toggle="yes">E. coli</italic>&#x02019;s heterologous expression of PKS, NRPS, and PKS/NRPS hybrid biosynthetic pathways has been proved to be more difficult [<xref rid="B40-marinedrugs-20-00341" ref-type="bibr">40</xref>].</p></sec><sec id="sec2dot2-marinedrugs-20-00341"><title>2.2. Cyanobacteria</title><p>Cyanobacterial MNPs are diverse in structure and bioactivity, and more than 1100 SMs have been identified from cyanobacteria, most of which are produced by four genera: <italic toggle="yes">Hapalosiphon</italic>, <italic toggle="yes">lyngbya</italic> (<italic toggle="yes">Moorea</italic>), <italic toggle="yes">Microcystis,</italic> and <italic toggle="yes">Nostoc</italic> [<xref rid="B89-marinedrugs-20-00341" ref-type="bibr">89</xref>]. Known or predicted cyanobacterial MNPs account for approximately 20% of marine-derived small molecules currently used in clinical trials as well as the treatment of cancer, neurological disorders, infectious diseases, anti-inflammatory, and UV protection [<xref rid="B90-marinedrugs-20-00341" ref-type="bibr">90</xref>,<xref rid="B91-marinedrugs-20-00341" ref-type="bibr">91</xref>,<xref rid="B92-marinedrugs-20-00341" ref-type="bibr">92</xref>]. The molecular structures of cyanobacterial MNPs differ from terrestrial and freshwater species [<xref rid="B93-marinedrugs-20-00341" ref-type="bibr">93</xref>]. Cyanobacterial MNPs consist of nitrogen-rich scaffolds with distinguished structural diversity and usually have halogenated, methylated, and oxidative modifications [<xref rid="B94-marinedrugs-20-00341" ref-type="bibr">94</xref>]. Cyanobacterial MNPs are typically produced by PKS, NRPS, or a hybrid PKS/NRPS pathway with multiple tailoring steps [<xref rid="B95-marinedrugs-20-00341" ref-type="bibr">95</xref>]. <italic toggle="yes">Anabaena</italic> sp. PCC 7120 is a filamentous freshwater cyanobacterial strain that has been used as a model organism to study cellular differentiation, hydrogen production, and nitrogen reduction [<xref rid="B58-marinedrugs-20-00341" ref-type="bibr">58</xref>]. It has not been reported that PCC 7120 produces its own bioactive metabolites from the NRPS/PKS clusters, which provides a clear and clean compound background for genetic manipulation. In addition, PCC 7120 can apply established genetic tools and recognize the promoters of BGCs from different marine cyanobacteria, which can be used as an ideal heterologous host to express cyanobacterial MNPs. Videau et al. [<xref rid="B58-marinedrugs-20-00341" ref-type="bibr">58</xref>] expressed the <italic toggle="yes">ltx</italic> gene from <italic toggle="yes">Moorea producens</italic> in PCC 7120 and successfully obtained a 13-fold titer of the cytotoxic lyngbyatoxin A. Taton et al. [<xref rid="B57-marinedrugs-20-00341" ref-type="bibr">57</xref>] used TAR cloning to clone the long cryptomaldamide BGC (28.7 kb) of <italic toggle="yes">M. producens</italic> JHB, which was then integrated into PCC 7120 and successfully expressed.</p></sec><sec id="sec2dot3-marinedrugs-20-00341"><title>2.3. Actinomycetes</title><p>High-GC-content Gram-positive mycelium bacteria are the microbial source of approximately two-thirds of known antibiotics [<xref rid="B96-marinedrugs-20-00341" ref-type="bibr">96</xref>]. By sequencing the actinomycete genomes, researchers have identified numerous cryptic BGCs of SMs with unknown function that may provide novel antibiotics for clinical use [<xref rid="B97-marinedrugs-20-00341" ref-type="bibr">97</xref>]. <italic toggle="yes">Streptomyces</italic> are particularly well known for producing medicinal compounds with antimicrobial and antitumor activity [<xref rid="B98-marinedrugs-20-00341" ref-type="bibr">98</xref>], and <italic toggle="yes">Streptomyces</italic> can even be processed into insecticides [<xref rid="B99-marinedrugs-20-00341" ref-type="bibr">99</xref>] and herbicides [<xref rid="B100-marinedrugs-20-00341" ref-type="bibr">100</xref>]. <italic toggle="yes">S. coelicolor</italic> A3(2) is a model species for studying the genetics and biology of actinomycetes, and a large number of genetic tools can be applied in this strain. After knocking out the BGCs of its main SMs, a series of heterologous expression hosts such as <italic toggle="yes">S. coelicolor</italic> M1146, M1152, and M1154 were constructed [<xref rid="B101-marinedrugs-20-00341" ref-type="bibr">101</xref>]. Chen et al. [<xref rid="B44-marinedrugs-20-00341" ref-type="bibr">44</xref>] heterologously expressed the <italic toggle="yes">kmy</italic> cluster in <italic toggle="yes">S. coelicolor</italic> M1152 to generate kendomycin B, which had strong antibacterial activity and moderate tumor cytotoxicity. The BGC was derived from a marine rare actinomycetes <italic toggle="yes">Verrucossppora</italic> sp. SCSIO 07399. This strain has a poor sporulation ability and slow growth rate, which hinders the stable production of kendomycin B. However, heterologous expression has improved the efficiency of researchers to obtain this MNP. Rodriguez et al. [<xref rid="B51-marinedrugs-20-00341" ref-type="bibr">51</xref>] identified the BGC and pathway for the antibiotic nybomycin from <italic toggle="yes">S. albus</italic> subsp. <italic toggle="yes">chlorinus</italic> NRRL B-24108 by heterogeneously expressing it in <italic toggle="yes">S. albus</italic> De114, a host without endogenous BGC interference. Zhang et al. [<xref rid="B55-marinedrugs-20-00341" ref-type="bibr">55</xref>] chose to develop a chassis strain marine actinomycete <italic toggle="yes">Salinispora tropical</italic> CNB-4401, which served as an ideal heterologous host to express BGCs. The researchers replaced the three genes (<italic toggle="yes">sal</italic>A-C) essential for the synthesis of salinosporamide in <italic toggle="yes">Salinispora tropical</italic> CNB-440 by a knockout cassette containing the phage attachment site <italic toggle="yes">attB</italic> of <italic toggle="yes">S. coelicolor</italic> &#x003a6;C31, resulting in the mutant <italic toggle="yes">S. tropica</italic> CNB-4401, which simplifies the chemical background of the original strain <italic toggle="yes">S. tropical</italic> CNB-440. The researchers successfully integrated and expressed the thiolactomycin BGC in <italic toggle="yes">S. tropica</italic> CNB-4401, validating the effectiveness of this new heterologous host. Compared to <italic toggle="yes">S. coelicolor</italic> M1152, <italic toggle="yes">S. tropica</italic> CNB-4401 produces approximately a threefold higher titer of thiolactomycin. This is the first example of utilizing marine actinomycetes as heterologous hosts for the expression of BGCs, providing an effective platform for accelerating the discovery of new MNPs and engineered biosynthesis pathways.</p></sec><sec id="sec2dot4-marinedrugs-20-00341"><title>2.4. Others</title><p><italic toggle="yes">Bacillus subtilis</italic> is a typical host with a low GC content and a frequently used heterologous expression platform where multiple molecular tools are applied [<xref rid="B102-marinedrugs-20-00341" ref-type="bibr">102</xref>]. Li et al. [<xref rid="B56-marinedrugs-20-00341" ref-type="bibr">56</xref>] cloned a large amicoumacin BGC from marine isolate <italic toggle="yes">Bacillus subtilis</italic> 1779 and activated this BGC in the host <italic toggle="yes">B. subtilis</italic>. Two intermediates of amicoumacin were detected. Apart from <italic toggle="yes">E. coli</italic> and <italic toggle="yes">Synechococcus</italic>, <italic toggle="yes">Myxococcus xanthus</italic> is also a good Gram-negative strain for heterologous expression and an antifungal agent haliangicin from a marine myxobacterium was produced with high efficiency in <italic toggle="yes">M</italic>. <italic toggle="yes">xanthus</italic> [<xref rid="B81-marinedrugs-20-00341" ref-type="bibr">81</xref>].</p><p>Yeasts are single-cell model eukaryotes that have been used as heterologous hosts to express biosynthetic pathways from microbes [<xref rid="B103-marinedrugs-20-00341" ref-type="bibr">103</xref>]. <italic toggle="yes">S. cerevisiae</italic> shows a high affinity of codon usage and a certain tolerance to exogenous bacterial sequences [<xref rid="B104-marinedrugs-20-00341" ref-type="bibr">104</xref>]. In addition, yeasts produce few endogenous SMs, minimizing competition of exogenous BGCs with cognate SM pathways and thus simplifying the detection and purification of target compounds [<xref rid="B105-marinedrugs-20-00341" ref-type="bibr">105</xref>]. The heterologous expression of BGCs from terrestrial bacteria and fungi has been proved workable in yeasts, while there have been few successful examples of BGCs from marine microorganisms expressed in yeasts. Many filamentous fungi are potential hosts for heterologous expression of fungal BGCs. Since filamentous fungi have highly developed secondary metabolic systems, they contain functional PPTases essential for the biosynthesis of fungal NPs. Furthermore, filamentous fungi were shown to recognize and correctly splice introns in exogenous fungal mRNA sequences without the need to clone and purify intron-free cDNAs from BGCs [<xref rid="B106-marinedrugs-20-00341" ref-type="bibr">106</xref>]. In addition, for the heterologous expression of fungal BGCs, since filamentous fungi are closely related, <italic toggle="yes">Aspergillus</italic> usually shows a good compatibility in codon usage, which facilitates translation [<xref rid="B107-marinedrugs-20-00341" ref-type="bibr">107</xref>]. Among filamentous fungal hosts, <italic toggle="yes">Aspergillus</italic> species such as <italic toggle="yes">Aspergillus nidulans</italic>, <italic toggle="yes">Aspergillus niger</italic>, and <italic toggle="yes">Aspergillus oryzae</italic> have been developed as efficient platforms for heterologous expression after the knockout of background metabolic pathways. The researchers cloned the BGC of beauvericin from marine-derived <italic toggle="yes">Fusarium proliferatum</italic> LF061 into the host <italic toggle="yes">A. nidulans</italic> [<xref rid="B82-marinedrugs-20-00341" ref-type="bibr">82</xref>]. The host successfully yielded beauvericin and the production was hundreds of times higher by replacing strong promoters and optimizing fermentation conditions. Despite the rapid progress in heterologous expression of terrestrial fungal NPs, the genetic tools for heterologous expression and homologous manipulation of marine fungi are still scarce, and the methods for terrestrial heterologous expression need to be transferred to the field of marine fungi [<xref rid="B108-marinedrugs-20-00341" ref-type="bibr">108</xref>].</p><p>Microalgae are promising heterologous hosts for MNPs. Microalgae with chloroplasts serve as photosynthetic production platforms, meaning that microalgae can grow rapidly by converting CO<sub>2</sub> into energy without the need of nutritious carbon sources. Using marine microalgae as host strains, several studies have heterologously expressed the genes encoding key enzymes in the biosynthetic pathways of terrestrial plants [<xref rid="B109-marinedrugs-20-00341" ref-type="bibr">109</xref>,<xref rid="B110-marinedrugs-20-00341" ref-type="bibr">110</xref>,<xref rid="B111-marinedrugs-20-00341" ref-type="bibr">111</xref>]. For the exploration of MNPs, Maeda [<xref rid="B83-marinedrugs-20-00341" ref-type="bibr">83</xref>] inserted a <italic toggle="yes">cox</italic> gene derived from a red alga into a genetically engineered microalgal host <italic toggle="yes">Fistulifera solaris</italic>. The <italic toggle="yes">cox</italic> gene encoded the biosynthesis of cyclooxygenase. This enzyme catalyzed the transformation of the rich C20 polyunsaturated fatty acids in <italic toggle="yes">F. solaris</italic> into prostaglandins with high production.</p></sec></sec><sec id="sec3-marinedrugs-20-00341"><title>3. Genetic Manipulations for BGCs</title><sec id="sec3dot1-marinedrugs-20-00341"><title>3.1. BGC Cloning</title><p>Due to the large size, high repeatability, and high GC content of BGCs in many microorganisms, cloning BGCs is a challenging and critical step for heterologous expression [<xref rid="B10-marinedrugs-20-00341" ref-type="bibr">10</xref>]. With advances in genome sequencing, bioinformatics and molecular biology techniques, many different types of cloning methods have been developed for the heterologous expression of MNPs. Large BGCs can be reconstructed from multiple amplified PCR fragments. Researchers have implemented a variety of BGC cloning or DNA assembly methods, including in vivo cloning and in vitro assembly. In vitro assembly is classic and straightforward, but it is constricted by enzymes, and library-based methods need laborious screening. In vivo cloning methods are flexible, while random mutations in sequences and incorrect ligation of DNA fragments cannot be circumvented either. The methods used in cloning MNP BGCs, as well as their advantages and disadvantages are listed in <xref rid="marinedrugs-20-00341-t002" ref-type="table">Table 2</xref>.</p><p>In vivo cloning methods are used to reconstitute large microbial BGCs. Transformation-associated recombination (TAR) cloning [<xref rid="B112-marinedrugs-20-00341" ref-type="bibr">112</xref>] is a prevalent method for cloning large size BGCs of MNPs. It exploits the yeast&#x02019;s natural in vivo homologous recombination (HR) activity. Once the site-specific sequences at both ends of the linearized TAR cloning vector match the target genome sites, the HR of gDNA fragments in yeast competent cells starts [<xref rid="B113-marinedrugs-20-00341" ref-type="bibr">113</xref>]. The reconstructed TAR cloning vector is then shuttled into <italic toggle="yes">E. coli</italic> for subsequent propagation, verification, and sequencing (<xref rid="marinedrugs-20-00341-f002" ref-type="fig">Figure 2</xref>a). TAR cloning vectors can also carry factors necessary for transport and a stable presence in a heterologous host. A 67 kb NRPS BGC from the marine actinomycete <italic toggle="yes">Saccharomonospora</italic> sp. CNQ-490 was integrated and captured using the yeast&#x02013;<italic toggle="yes">E. coli</italic>&#x02013;<italic toggle="yes">Streptomyces</italic> shuttle vector <italic toggle="yes">pCAP01</italic> and activated in the model actinomycete <italic toggle="yes">S. coelicolor</italic> [<xref rid="B48-marinedrugs-20-00341" ref-type="bibr">48</xref>]. The lipopeptide antibiotic taromycin A was synthesized and expressed. &#x003bb;/Red [<xref rid="B114-marinedrugs-20-00341" ref-type="bibr">114</xref>] and Red/ET [<xref rid="B115-marinedrugs-20-00341" ref-type="bibr">115</xref>] systems exhibit a strong ability of HR in <italic toggle="yes">E. coli</italic> by virtue of the efficient phage-recombinases from the &#x003bb; phage, and these two methods are continuously improved to directly clone DNA segments from complex genomes of marine microorganisms. Phage recombinases also function in a serine integrase recombination assembly (SIRA) [<xref rid="B116-marinedrugs-20-00341" ref-type="bibr">116</xref>]. These enzymes catalyze and recognize <italic toggle="yes">attP</italic> and <italic toggle="yes">attB</italic> sites to generate new <italic toggle="yes">attL</italic> and <italic toggle="yes">attR</italic> sequence linkages (<xref rid="marinedrugs-20-00341-f002" ref-type="fig">Figure 2</xref>b). In this way, DNA fragments can be spliced together in a specific order and orientation to form a self-replicating structure and selectable markers.</p><p>Cosmid and fosmid libraries [<xref rid="B117-marinedrugs-20-00341" ref-type="bibr">117</xref>,<xref rid="B118-marinedrugs-20-00341" ref-type="bibr">118</xref>] are the commonly used in vitro cloning methods for MNP BGCs, since the construction of an open reading frame library assists in the rapid screening for BGCs with bioactivity from marine metagenomes. Large DNA fragments are carried in cosmid or fosmid vectors, from which researchers segregate the clones containing useful BGCs. The restriction enzyme-mediated assembly is a conventional in vitro assembly method which heavily relies on type IIs restriction enzymes for the cutting and ligation of DNA fragments. Many studies of heterologous expression of marine-derived enzymes in <italic toggle="yes">E. coli</italic> have been achieved by this simple method. Bacterial artificial chromosome (BAC) [<xref rid="B119-marinedrugs-20-00341" ref-type="bibr">119</xref>] vectors can replicate in stable condition in <italic toggle="yes">E. coli</italic> and increase DNA yield, particularly suitable for cloning BGCs into bacterial hosts. The overlap extension PCR method [<xref rid="B120-marinedrugs-20-00341" ref-type="bibr">120</xref>] uses primers with complementary ends to assemble multiple overlapping DNA fragments obtained by standard PCR into a full-length double-stranded DNA (<xref rid="marinedrugs-20-00341-f002" ref-type="fig">Figure 2</xref>c). The Gibson assembly [<xref rid="B121-marinedrugs-20-00341" ref-type="bibr">121</xref>] is another in vitro method for joining multiple DNA fragments with the help of 5&#x02032; exonuclease (<xref rid="marinedrugs-20-00341-f002" ref-type="fig">Figure 2</xref>d). Wang [<xref rid="B122-marinedrugs-20-00341" ref-type="bibr">122</xref>] systematically and comprehensively reviewed the latest BGC cloning methods.</p></sec><sec id="sec3dot2-marinedrugs-20-00341"><title>3.2. BGC Regulation</title><p>Although the heterologous expression of BGCs in model hosts is a robust way to increase the production of MNPs, it still faces many problems due to the difference between the host and native strains in metabolic regulation, precursor supply, auxiliary factors, and the self-resistance, such as the lack of regulation of gene expression, the difficulty of recruiting the premise modules, and the inefficient transcription and translation of BGCs [<xref rid="B13-marinedrugs-20-00341" ref-type="bibr">13</xref>,<xref rid="B33-marinedrugs-20-00341" ref-type="bibr">33</xref>]. Therefore, it is important to rationally design and regulate BGCs and heterologous hosts to improve the biosynthetic efficiency of MNPs. At the same time, the expression of known BGCs in heterologous hosts may lead to the generation of new derivatives, which may be the result of incompatible metabolic systems or nonpathway modification of compounds by endogenous enzymes [<xref rid="B40-marinedrugs-20-00341" ref-type="bibr">40</xref>]. Kim et al. [<xref rid="B41-marinedrugs-20-00341" ref-type="bibr">41</xref>] heterologously expressed the entire barbamide BGC in an engineered strain of <italic toggle="yes">S. venezuelae</italic> DHS 2001 in which the picromycin PKS BGC was deleted, and obtained 4-<italic toggle="yes">O</italic>-Demethylbarbamide, a new derivative of barbamide which lacks one <italic toggle="yes">O</italic>-methyl. The molluscicidal activity of this new derivative was several times higher than that of the original structure, which was also the first study on the successful heterologous expression of the marine cyanobacterial NRPS/PKS BGC in a terrestrial host. The selection of a suitable host combined with the stable expression of exogenous genes after genetic engineering in hosts provide an important fundamental for biosynthesis and molecular engineering to study new MNPs. At present, two regulation methods for BGCs have been applied to develop MNPs, including (1) activating the cryptic pathway with a strong promoter; and (2) supplementing and directing the transport of precursor molecules.</p><p>Promoters are critical for transcription, while endogenous promoters of BGCs are usually not compatible with heterologous hosts unless they are closely related enough to successfully initiate gene transcription and regulation [<xref rid="B123-marinedrugs-20-00341" ref-type="bibr">123</xref>]. Thus, the heterologous expression of BGCs requires the simultaneous high-level expression of multiple promoters and controllable initiation of MNP biosynthesis under appropriate circumstances. Currently, constitutive promoters from housekeeping genes and inducible promoters from major metabolic genes are often used to drive the expression of BGCs in commonly used heterologous expression systems [<xref rid="B21-marinedrugs-20-00341" ref-type="bibr">21</xref>]. Bauman et al. [<xref rid="B49-marinedrugs-20-00341" ref-type="bibr">49</xref>] discovered, cloned, reconstructed, and heterologously expressed a cryptohybrid phenoazine-type BGC (<italic toggle="yes">spz</italic>) from the marine actinomycetes <italic toggle="yes">Streptomyces</italic> sp. CNB-091. The researchers introduced three promoter cassettes to reconstitute the <italic toggle="yes">spz</italic> cluster. An engineered bidirectional promoter combining the strong synthetic promoters <italic toggle="yes">p21</italic> and <italic toggle="yes">sp44</italic> was introduced into the cluster to control the biosynthesis of the core genes; the <italic toggle="yes">actI</italic> promoter was used to control the PKS gene of the <italic toggle="yes">spz</italic> cluster; the <italic toggle="yes">ermE*</italic> promoter was used to regulate the expression of the cytochrome <italic toggle="yes">bd</italic> oxidase gene. Overexpression of the <italic toggle="yes">spz</italic> cluster increased the yield and chemical diversity of phenazine MNPs, and the researchers detected at least 38 streptomycin phenazines from the fermentation liquor.</p><p>Some MNPs are produced in very low yields, and even heterologous expression systems using strong promoters may not necessarily produce sufficient amounts of the required compounds. This low yield severely limits the characterization of marine bioactive molecules and reduces their industrial production. This limitation may be circumvented by enhancing precursor supply to facilitate MNP biosynthesis [<xref rid="B124-marinedrugs-20-00341" ref-type="bibr">124</xref>]. Marine myxomycete <italic toggle="yes">Haliangium ochraceum</italic> SMP-2 produces the antifungal polyketide haliangicin, but its yield is low. BGC <italic toggle="yes">hli</italic> (47.8 kb), which encodes haliangicin, has been identified and expressed in <italic toggle="yes">Myxococcus xanthus</italic> to assure the efficient production of haliangicin. It showed that the titer of haliangicin increased significantly when the precursor concentration was greater than 50 mM. When the concentration reached 200 mM, haliangicin at a concentration of 11.0 &#x000b1; 2.1 mg/L was detected after 5 d. Compared with the original strain, the yield increased 10 times and the growth rate increased 3 times [<xref rid="B81-marinedrugs-20-00341" ref-type="bibr">81</xref>].</p><p>Recently, CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats) [<xref rid="B125-marinedrugs-20-00341" ref-type="bibr">125</xref>] has unleashed its great potential in genetic manipulation, especially showing tremendous advantages over traditional techniques in the efficient site-specific mutagenesis and in-frame deletions. By using CRISPR-Cas9, researchers are able to delete or replace the predicted key gene loci of connate BGCs in host strains, blocking these biosynthetic pathways, reducing the production of SMs and thus forcing more substrates to get involved in the biosynthesis of exogenous BGCs. Moreover, researchers can use CRISPR-Cas9-mediated knock-in strategy to precisely introduce promoter cassettes to replace original promoter regions, which might stimulate the high expression of inserted BGCs or produce new derivatives. Several experiments have succeeded in activating <italic toggle="yes">Streptomyces</italic> and cyanobacteria BGCs [<xref rid="B126-marinedrugs-20-00341" ref-type="bibr">126</xref>,<xref rid="B127-marinedrugs-20-00341" ref-type="bibr">127</xref>], and the CRISPR-Cas9 technique can possibly be extended to more heterologous expression systems. For microalgal hosts, TALEN (Transcription activator-like effector nucleases) [<xref rid="B128-marinedrugs-20-00341" ref-type="bibr">128</xref>] could be a feasible genome editing approach. TALEN introduces double strand breaks at a specific locus and causes the host to self-repair the damage. If a DNA sequence with a strong homology to the sequence around the cutting site is provided, the HR mechanism in cells works and use the provided DNA sequence as a template to repair the break, which achieves the accurate replacement of DNA. Serif [<xref rid="B129-marinedrugs-20-00341" ref-type="bibr">129</xref>] has established a TALEN-mediated gene knockout protocol for the model diatom <italic toggle="yes">Phaeodactylum tricornutum</italic>, which might be a reliable approach for genetic engineering in microalgal hosts.</p></sec></sec><sec sec-type="conclusions" id="sec4-marinedrugs-20-00341"><title>4. Conclusions</title><p>The marine environment covers millions of phylogenetically distinct microorganisms, providing a treasure trove of biochemical diversity. The marine environment has unique characteristics compared with other terrestrial ecosystems, which are often reflected in the physicochemical properties and bioactivity of MNPs [<xref rid="B130-marinedrugs-20-00341" ref-type="bibr">130</xref>]. However, the biosynthetic pathways of most MNPs remain underexplored. Moreover, many marine strains have low or no expression of BGCs on usual standard media, resulting in low natural yields or the inability to synthesize MNPs [<xref rid="B131-marinedrugs-20-00341" ref-type="bibr">131</xref>,<xref rid="B132-marinedrugs-20-00341" ref-type="bibr">132</xref>,<xref rid="B133-marinedrugs-20-00341" ref-type="bibr">133</xref>]. An effective way to mine potential MNPs is through the heterologous expression of BGCs, expressing exogenous target BGCs in characterized hosts, and using advanced genetic engineering techniques to regulate this process [<xref rid="B13-marinedrugs-20-00341" ref-type="bibr">13</xref>,<xref rid="B134-marinedrugs-20-00341" ref-type="bibr">134</xref>,<xref rid="B135-marinedrugs-20-00341" ref-type="bibr">135</xref>]. With advances in DNA sequencing technology and bioinformatics tools, researchers have identified a huge potential for untapped MNPs biosynthesis. Compared to terrestrial compounds, the development of MNPs biosynthesis in heterologous hosts has barely started. Natural products from land have undergone biosynthesis with heterologous expression, with 40 from fungi alone [<xref rid="B21-marinedrugs-20-00341" ref-type="bibr">21</xref>], whereas only 46 BGCs from marine bacteria, fungi, cyanobacteria, microalgae, and marine metagenomes have been studied with heterologous expression as mentioned in this review. Therefore, the heterologous expression of cryptic or unknown MNPs BGCs is likely to be the next research front. The biggest obstacle for exploiting MNPs is how to mimic the culture environment, such as the adjustment of the pH, salt concentration, and composition at seawater level, let alone microbes growing near hydrothermal vents and the deep trench. Among microorganisms, it is harder for a fungal host to coexpress the entire BGC, which requires the coordination of multiple promoters working at the appropriate time [<xref rid="B21-marinedrugs-20-00341" ref-type="bibr">21</xref>]. Moreover, genetic manipulations are relatively intractable in more complex fungal hosts. However, generally, fungal BGCs are more likely to heterologously express in the fungal hosts. The above problems, therefore, might combine to cause difficulties for the heterologous expression of marine-derive fungal BGCs.</p><p>Efficient heterologous hosts and precise genetic manipulations are critical challenges for the heterologous expression of marine-derived BGCs. Perhaps in the future, the genetic tools of terrestrial hosts can be extended to marine microorganisms, and the technologies of genetic manipulations may make rapid progress, greatly reducing the cost and time of experiments. In addition, the establishment of various transcriptional regulatory factors, including promoters, ribosome binding sites, and terminators, will expand the toolbox of gene manipulation, allowing researchers to redesign and assemble BGCs and even complete the artificial biosynthesis of pathways. Finally, the comprehensive application of multiomics, including genomics, transcriptomics, proteomics, and metabolomics, can be integrated in heterologous expression platforms to overcome the difficulties of the industrial production of MNPs through a systematic strategy.</p></sec></body><back><ack><title>Acknowledgments</title><p>Yushan Xu was supported by the Student Research Training Program (Zhejiang University, project number 202110335149).</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, Y.X., X.D., X.Y. and P.W.; writing&#x02014;original draft preparation, Y.X., X.D. and X.Y.; writing&#x02014;review and editing, Q.J. and J.X.; visualization, Q.J. and K.Z.; supervision, P.W.; funding acquisition, P.W. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-marinedrugs-20-00341"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>DeLong</surname><given-names>E.F.</given-names></name>
<name><surname>Karl</surname><given-names>D.M.</given-names></name>
</person-group><article-title>Genomic perspectives in microbial oceanography</article-title><source>Nature</source><year>2005</year><volume>437</volume><fpage>336</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1038/nature04157</pub-id><?supplied-pmid 16163343?><pub-id pub-id-type="pmid">16163343</pub-id></element-citation></ref><ref id="B2-marinedrugs-20-00341"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Amiri Moghaddam</surname><given-names>J.</given-names></name>
<name><surname>Jautzus</surname><given-names>T.</given-names></name>
<name><surname>Alanjary</surname><given-names>M.</given-names></name>
<name><surname>Beemelmanns</surname><given-names>C.</given-names></name>
</person-group><article-title>Recent highlights of biosynthetic studies on marine natural products</article-title><source>Org. Biomol. Chem.</source><year>2021</year><volume>19</volume><fpage>123</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1039/D0OB01677B</pub-id><?supplied-pmid 33216100?><pub-id pub-id-type="pmid">33216100</pub-id></element-citation></ref><ref id="B3-marinedrugs-20-00341"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Molinski</surname><given-names>T.F.</given-names></name>
<name><surname>Dalisay</surname><given-names>D.S.</given-names></name>
<name><surname>Lievens</surname><given-names>S.L.</given-names></name>
<name><surname>Saludes</surname><given-names>J.P.</given-names></name>
</person-group><article-title>Drug development from marine natural products</article-title><source>Nat. Rev. Drug Discovery</source><year>2009</year><volume>8</volume><fpage>69</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1038/nrd2487</pub-id><?supplied-pmid 19096380?><pub-id pub-id-type="pmid">19096380</pub-id></element-citation></ref><ref id="B4-marinedrugs-20-00341"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ameen</surname><given-names>F.</given-names></name>
<name><surname>AlNadhari</surname><given-names>S.</given-names></name>
<name><surname>Al-Homaidan</surname><given-names>A.A.</given-names></name>
</person-group><article-title>Marine microorganisms as an untapped source of bioactive compounds</article-title><source>Saudi J. Biol. Sci.</source><year>2021</year><volume>28</volume><fpage>224</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1016/j.sjbs.2020.09.052</pub-id><pub-id pub-id-type="pmid">33424301</pub-id></element-citation></ref><ref id="B5-marinedrugs-20-00341"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jimenez</surname><given-names>C.</given-names></name>
</person-group><article-title>Marine Natural Products in Medicinal Chemistry</article-title><source>ACS. Med. Chem. Lett.</source><year>2018</year><volume>9</volume><fpage>959</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1021/acsmedchemlett.8b00368</pub-id><pub-id pub-id-type="pmid">30344898</pub-id></element-citation></ref><ref id="B6-marinedrugs-20-00341"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Simon</surname><given-names>C.</given-names></name>
<name><surname>Daniel</surname><given-names>R.</given-names></name>
</person-group><article-title>Metagenomic analyses: Past and future trends</article-title><source>Appl. Environ. Microbiol.</source><year>2011</year><volume>77</volume><fpage>1153</fpage><lpage>1161</lpage><pub-id pub-id-type="doi">10.1128/AEM.02345-10</pub-id><pub-id pub-id-type="pmid">21169428</pub-id></element-citation></ref><ref id="B7-marinedrugs-20-00341"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Imhoff</surname><given-names>J.F.</given-names></name>
<name><surname>Labes</surname><given-names>A.</given-names></name>
<name><surname>Wiese</surname><given-names>J.</given-names></name>
</person-group><article-title>Bio-mining the microbial treasures of the ocean: New natural products</article-title><source>Biotechnol. Adv.</source><year>2011</year><volume>29</volume><fpage>468</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2011.03.001</pub-id><pub-id pub-id-type="pmid">21419836</pub-id></element-citation></ref><ref id="B8-marinedrugs-20-00341"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>An</surname><given-names>R.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Sun</surname><given-names>N.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Hu</surname><given-names>J.</given-names></name>
<name><surname>Kuai</surname><given-names>J.</given-names></name>
</person-group><article-title>Exploring novel bioactive compounds from marine microbes</article-title><source>Curr. Opin. Microbiol.</source><year>2005</year><volume>8</volume><fpage>276</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2005.04.008</pub-id><pub-id pub-id-type="pmid">15939350</pub-id></element-citation></ref><ref id="B9-marinedrugs-20-00341"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lindequist</surname><given-names>U.</given-names></name>
</person-group><article-title>Marine-Derived Pharmaceuticals&#x02014;Challenges and Opportunities</article-title><source>Biomol. Ther.</source><year>2016</year><volume>24</volume><fpage>561</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.4062/biomolther.2016.181</pub-id></element-citation></ref><ref id="B10-marinedrugs-20-00341"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>J.J.</given-names></name>
<name><surname>Tang</surname><given-names>X.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
</person-group><article-title>Genetic platforms for heterologous expression of microbial natural products</article-title><source>Nat. Prod. Rep.</source><year>2019</year><volume>36</volume><fpage>1313</fpage><lpage>1332</lpage><pub-id pub-id-type="doi">10.1039/C9NP00025A</pub-id><pub-id pub-id-type="pmid">31197291</pub-id></element-citation></ref><ref id="B11-marinedrugs-20-00341"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reen</surname><given-names>F.J.</given-names></name>
<name><surname>Romano</surname><given-names>S.</given-names></name>
<name><surname>Dobson</surname><given-names>A.D.</given-names></name>
<name><surname>O&#x02019;Gara</surname><given-names>F.</given-names></name>
</person-group><article-title>The Sound of Silence: Activating Silent Biosynthetic Gene Clusters in Marine Microorganisms</article-title><source>Mar. Drugs</source><year>2015</year><volume>13</volume><fpage>4754</fpage><lpage>4783</lpage><pub-id pub-id-type="doi">10.3390/md13084754</pub-id><?supplied-pmid 26264003?><pub-id pub-id-type="pmid">26264003</pub-id></element-citation></ref><ref id="B12-marinedrugs-20-00341"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Panter</surname><given-names>F.</given-names></name>
<name><surname>Bader</surname><given-names>C.D.</given-names></name>
<name><surname>Muller</surname><given-names>R.</given-names></name>
</person-group><article-title>Synergizing the potential of bacterial genomics and metabolomics to find novel antibiotics</article-title><source>Chem. Sci.</source><year>2021</year><volume>12</volume><fpage>5994</fpage><lpage>6010</lpage><pub-id pub-id-type="doi">10.1039/D0SC06919A</pub-id><?supplied-pmid 33995996?><pub-id pub-id-type="pmid">33995996</pub-id></element-citation></ref><ref id="B13-marinedrugs-20-00341"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>Q.</given-names></name>
<name><surname>Hotta</surname><given-names>K.</given-names></name>
<name><surname>Deng</surname><given-names>Y.</given-names></name>
<name><surname>Yuan</surname><given-names>R.</given-names></name>
<name><surname>Quan</surname><given-names>S.</given-names></name>
<name><surname>Chen</surname><given-names>X.</given-names></name>
</person-group><article-title>Advances in Biosynthesis of Natural Products from Marine Microorganisms</article-title><source>Microorganisms</source><year>2021</year><volume>9</volume><elocation-id>2551</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms9122551</pub-id><pub-id pub-id-type="pmid">34946152</pub-id></element-citation></ref><ref id="B14-marinedrugs-20-00341"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kalaitzis</surname><given-names>J.A.</given-names></name>
<name><surname>Ingrey</surname><given-names>S.D.</given-names></name>
<name><surname>Chau</surname><given-names>R.</given-names></name>
<name><surname>Simon</surname><given-names>Y.</given-names></name>
<name><surname>Neilan</surname><given-names>B.A.</given-names></name>
</person-group><article-title>Genome-guided discovery of natural products and biosynthetic pathways from Australia&#x02019;s untapped microbial megadiversity</article-title><source>Aust. J. Chem.</source><year>2015</year><volume>69</volume><fpage>129</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1071/CH15601</pub-id></element-citation></ref><ref id="B15-marinedrugs-20-00341"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ziemert</surname><given-names>N.</given-names></name>
<name><surname>Alanjary</surname><given-names>M.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
</person-group><article-title>The evolution of genome mining in microbes&#x02013;a review</article-title><source>Nat. Prod. Rep.</source><year>2016</year><volume>33</volume><fpage>988</fpage><lpage>1005</lpage><pub-id pub-id-type="doi">10.1039/C6NP00025H</pub-id><?supplied-pmid 27272205?><pub-id pub-id-type="pmid">27272205</pub-id></element-citation></ref><ref id="B16-marinedrugs-20-00341"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>J.Y.</given-names></name>
<name><surname>Sanchez</surname><given-names>L.M.</given-names></name>
<name><surname>Rath</surname><given-names>C.M.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Boudreau</surname><given-names>P.D.</given-names></name>
<name><surname>Bruns</surname><given-names>N.</given-names></name>
<name><surname>Glukhov</surname><given-names>E.</given-names></name>
<name><surname>Wodtke</surname><given-names>A.</given-names></name>
<name><surname>De Felicio</surname><given-names>R.</given-names></name>
<name><surname>Fenner</surname><given-names>A.</given-names></name>
</person-group><article-title>Molecular networking as a dereplication strategy</article-title><source>J. Nat. Prod.</source><year>2013</year><volume>76</volume><fpage>1686</fpage><lpage>1699</lpage><pub-id pub-id-type="doi">10.1021/np400413s</pub-id><pub-id pub-id-type="pmid">24025162</pub-id></element-citation></ref><ref id="B17-marinedrugs-20-00341"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Shaw</surname><given-names>S.</given-names></name>
<name><surname>Steinke</surname><given-names>K.</given-names></name>
<name><surname>Villebro</surname><given-names>R.</given-names></name>
<name><surname>Ziemert</surname><given-names>N.</given-names></name>
<name><surname>Lee</surname><given-names>S.Y.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
</person-group><article-title>antiSMASH 5.0: Updates to the secondary metabolite genome mining pipeline</article-title><source>Nucleic Acids Res.</source><year>2019</year><volume>47</volume><fpage>W81</fpage><lpage>W87</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz310</pub-id><pub-id pub-id-type="pmid">31032519</pub-id></element-citation></ref><ref id="B18-marinedrugs-20-00341"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lyu</surname><given-names>C.</given-names></name>
<name><surname>Chen</surname><given-names>T.</given-names></name>
<name><surname>Qiang</surname><given-names>B.</given-names></name>
<name><surname>Liu</surname><given-names>N.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Liu</surname><given-names>Z.</given-names></name>
</person-group><article-title>CMNPD: A comprehensive marine natural products database towards facilitating drug discovery from the ocean</article-title><source>Nucleic Acids Res.</source><year>2021</year><volume>49</volume><fpage>D509</fpage><lpage>D515</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa763</pub-id><pub-id pub-id-type="pmid">32986829</pub-id></element-citation></ref><ref id="B19-marinedrugs-20-00341"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ambrosino</surname><given-names>L.</given-names></name>
<name><surname>Tangherlini</surname><given-names>M.</given-names></name>
<name><surname>Colantuono</surname><given-names>C.</given-names></name>
<name><surname>Esposito</surname><given-names>A.</given-names></name>
<name><surname>Sangiovanni</surname><given-names>M.</given-names></name>
<name><surname>Miralto</surname><given-names>M.</given-names></name>
<name><surname>Sansone</surname><given-names>C.</given-names></name>
<name><surname>Chiusano</surname><given-names>M.L.</given-names></name>
</person-group><article-title>Bioinformatics for marine products: An overview of resources, bottlenecks, and perspectives</article-title><source>Mar. Drugs</source><year>2019</year><volume>17</volume><elocation-id>576</elocation-id><pub-id pub-id-type="doi">10.3390/md17100576</pub-id></element-citation></ref><ref id="B20-marinedrugs-20-00341"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bode</surname><given-names>H.B.</given-names></name>
<name><surname>Bethe</surname><given-names>B.</given-names></name>
<name><surname>H&#x000f6;fs</surname><given-names>R.</given-names></name>
<name><surname>Zeeck</surname><given-names>A.</given-names></name>
</person-group><article-title>Big effects from small changes: Possible ways to explore nature&#x02019;s chemical diversity</article-title><source>ChemBioChem</source><year>2002</year><volume>3</volume><fpage>619</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1002/1439-7633(20020703)3:7&#x0003c;619::AID-CBIC619&#x0003e;3.0.CO;2-9</pub-id><pub-id pub-id-type="pmid">12324995</pub-id></element-citation></ref><ref id="B21-marinedrugs-20-00341"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meng</surname><given-names>X.</given-names></name>
<name><surname>Fang</surname><given-names>Y.</given-names></name>
<name><surname>Ding</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Jia</surname><given-names>K.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Collemare</surname><given-names>J.</given-names></name>
<name><surname>Liu</surname><given-names>W.</given-names></name>
</person-group><article-title>Developing fungal heterologous expression platforms to explore and improve the production of natural products from fungal biodiversity</article-title><source>Biotechnol. Adv.</source><year>2022</year><volume>54</volume><fpage>107866</fpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2021.107866</pub-id><?supplied-pmid 34780934?><pub-id pub-id-type="pmid">34780934</pub-id></element-citation></ref><ref id="B22-marinedrugs-20-00341"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Myronovskyi</surname><given-names>M.</given-names></name>
<name><surname>Luzhetskyy</surname><given-names>A.</given-names></name>
</person-group><article-title>Native and engineered promoters in natural product discovery</article-title><source>Nat. Prod. Rep.</source><year>2016</year><volume>33</volume><fpage>1006</fpage><lpage>1019</lpage><pub-id pub-id-type="doi">10.1039/C6NP00002A</pub-id><?supplied-pmid 27438486?><pub-id pub-id-type="pmid">27438486</pub-id></element-citation></ref><ref id="B23-marinedrugs-20-00341"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Montiel</surname><given-names>D.</given-names></name>
<name><surname>Kang</surname><given-names>H.-S.</given-names></name>
<name><surname>Chang</surname><given-names>F.-Y.</given-names></name>
<name><surname>Charlop-Powers</surname><given-names>Z.</given-names></name>
<name><surname>Brady</surname><given-names>S.F.</given-names></name>
</person-group><article-title>Yeast homologous recombination-based promoter engineering for the activation of silent natural product biosynthetic gene clusters</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2015</year><volume>112</volume><fpage>8953</fpage><lpage>8958</lpage><pub-id pub-id-type="doi">10.1073/pnas.1507606112</pub-id><?supplied-pmid 26150486?><pub-id pub-id-type="pmid">26150486</pub-id></element-citation></ref><ref id="B24-marinedrugs-20-00341"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Choi</surname><given-names>S.S.</given-names></name>
<name><surname>Katsuyama</surname><given-names>Y.</given-names></name>
<name><surname>Bai</surname><given-names>L.</given-names></name>
<name><surname>Deng</surname><given-names>Z.</given-names></name>
<name><surname>Ohnishi</surname><given-names>Y.</given-names></name>
<name><surname>Kim</surname><given-names>E.S.</given-names></name>
</person-group><article-title>Genome engineering for microbial natural product discovery</article-title><source>Curr. Opin. Microbiol.</source><year>2018</year><volume>45</volume><fpage>53</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2018.02.007</pub-id><?supplied-pmid 29510374?><pub-id pub-id-type="pmid">29510374</pub-id></element-citation></ref><ref id="B25-marinedrugs-20-00341"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Griffiths</surname><given-names>S.</given-names></name>
<name><surname>Saccomanno</surname><given-names>B.</given-names></name>
<name><surname>de Wit</surname><given-names>P.J.</given-names></name>
<name><surname>Collemare</surname><given-names>J.</given-names></name>
</person-group><article-title>Regulation of secondary metabolite production in the fungal tomato pathogen <italic toggle="yes">Cladosporium fulvum</italic></article-title><source>Fungal Genet. Biol.</source><year>2015</year><volume>84</volume><fpage>52</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.fgb.2015.09.009</pub-id><pub-id pub-id-type="pmid">26415644</pub-id></element-citation></ref><ref id="B26-marinedrugs-20-00341"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Scherlach</surname><given-names>K.</given-names></name>
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
</person-group><article-title>Triggering cryptic natural product biosynthesis in microorganisms</article-title><source>Org. Biomol. Chem.</source><year>2009</year><volume>7</volume><fpage>1753</fpage><lpage>1760</lpage><pub-id pub-id-type="doi">10.1039/b821578b</pub-id><pub-id pub-id-type="pmid">19590766</pub-id></element-citation></ref><ref id="B27-marinedrugs-20-00341"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fujita</surname><given-names>M.J.</given-names></name>
<name><surname>Kimura</surname><given-names>N.</given-names></name>
<name><surname>Sakai</surname><given-names>A.</given-names></name>
<name><surname>Ichikawa</surname><given-names>Y.</given-names></name>
<name><surname>Hanyu</surname><given-names>T.</given-names></name>
<name><surname>Otsuka</surname><given-names>M.</given-names></name>
</person-group><article-title>Cloning and heterologous expression of the vibrioferrin biosynthetic gene cluster from a marine metagenomic library</article-title><source>Biosci. Biotechnol. Biochem.</source><year>2011</year><volume>75</volume><fpage>2283</fpage><lpage>2287</lpage><pub-id pub-id-type="doi">10.1271/bbb.110379</pub-id><pub-id pub-id-type="pmid">22146715</pub-id></element-citation></ref><ref id="B28-marinedrugs-20-00341"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Handelsman</surname><given-names>J.</given-names></name>
<name><surname>Liles</surname><given-names>M.</given-names></name>
<name><surname>Mann</surname><given-names>D.</given-names></name>
<name><surname>Riesenfeld</surname><given-names>C.</given-names></name>
<name><surname>Goodman</surname><given-names>R.M.</given-names></name>
</person-group><article-title>Cloning the metagenome: Culture-independent access to thediversity and functions of the uncultivated microbial world</article-title><source>Methods Microbiol.</source><year>2002</year><volume>33</volume><fpage>241</fpage><lpage>255</lpage></element-citation></ref><ref id="B29-marinedrugs-20-00341"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brady</surname><given-names>S.F.</given-names></name>
<name><surname>Chao</surname><given-names>C.J.</given-names></name>
<name><surname>Handelsman</surname><given-names>J.</given-names></name>
<name><surname>Clardy</surname><given-names>J.</given-names></name>
</person-group><article-title>Cloning and heterologous expression of a natural product biosynthetic gene cluster from eDNA</article-title><source>Org. Lett.</source><year>2001</year><volume>3</volume><fpage>1981</fpage><lpage>1984</lpage><pub-id pub-id-type="doi">10.1021/ol015949k</pub-id><pub-id pub-id-type="pmid">11418029</pub-id></element-citation></ref><ref id="B30-marinedrugs-20-00341"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sandargo</surname><given-names>B.</given-names></name>
<name><surname>Chepkirui</surname><given-names>C.</given-names></name>
<name><surname>Cheng</surname><given-names>T.</given-names></name>
<name><surname>Chaverra-Mu&#x000f1;oz</surname><given-names>L.</given-names></name>
<name><surname>Thongbai</surname><given-names>B.</given-names></name>
<name><surname>Stadler</surname><given-names>M.</given-names></name>
<name><surname>H&#x000fc;ttel</surname><given-names>S.</given-names></name>
</person-group><article-title>Biological and chemical diversity go hand in hand: Basidiomycota as source of new pharmaceuticals and agrochemicals</article-title><source>Biotechnol. Adv.</source><year>2019</year><volume>37</volume><fpage>107344</fpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2019.01.011</pub-id><pub-id pub-id-type="pmid">30738916</pub-id></element-citation></ref><ref id="B31-marinedrugs-20-00341"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zotchev</surname><given-names>S.B.</given-names></name>
</person-group><article-title>Marine actinomycetes as an emerging resource for the drug development pipelines</article-title><source>J. Biotechnol.</source><year>2012</year><volume>158</volume><fpage>168</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/j.jbiotec.2011.06.002</pub-id><?supplied-pmid 21683100?><pub-id pub-id-type="pmid">21683100</pub-id></element-citation></ref><ref id="B32-marinedrugs-20-00341"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dhakal</surname><given-names>D.</given-names></name>
<name><surname>Chen</surname><given-names>M.</given-names></name>
<name><surname>Luesch</surname><given-names>H.</given-names></name>
<name><surname>Ding</surname><given-names>Y.</given-names></name>
</person-group><article-title>Heterologous production of cyanobacterial compounds</article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2021</year><volume>48</volume><fpage>kuab003</fpage><pub-id pub-id-type="doi">10.1093/jimb/kuab003</pub-id><?supplied-pmid 33928376?><pub-id pub-id-type="pmid">33928376</pub-id></element-citation></ref><ref id="B33-marinedrugs-20-00341"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huo</surname><given-names>L.</given-names></name>
<name><surname>Hug</surname><given-names>J.J.</given-names></name>
<name><surname>Fu</surname><given-names>C.</given-names></name>
<name><surname>Bian</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Muller</surname><given-names>R.</given-names></name>
</person-group><article-title>Heterologous expression of bacterial natural product biosynthetic pathways</article-title><source>Nat. Prod. Rep.</source><year>2019</year><volume>36</volume><fpage>1412</fpage><lpage>1436</lpage><pub-id pub-id-type="doi">10.1039/C8NP00091C</pub-id><?supplied-pmid 30620035?><pub-id pub-id-type="pmid">30620035</pub-id></element-citation></ref><ref id="B34-marinedrugs-20-00341"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>G.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Zhu</surname><given-names>T.</given-names></name>
<name><surname>Gu</surname><given-names>Q.</given-names></name>
<name><surname>Li</surname><given-names>D.</given-names></name>
</person-group><article-title>Advanced tools in marine natural drug discovery</article-title><source>Curr. Opin. Biotechnol.</source><year>2016</year><volume>42</volume><fpage>13</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2016.02.021</pub-id><?supplied-pmid 26954946?><pub-id pub-id-type="pmid">26954946</pub-id></element-citation></ref><ref id="B35-marinedrugs-20-00341"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De</surname><given-names>B.C.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Zhang</surname><given-names>G.</given-names></name>
<name><surname>Liu</surname><given-names>Z.</given-names></name>
<name><surname>Tan</surname><given-names>B.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Zhu</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>C.</given-names></name>
</person-group><article-title>Host-dependent heterologous expression of berninamycin gene cluster leads to linear thiopeptide antibiotics</article-title><source>Org. Biomol. Chem.</source><year>2021</year><volume>19</volume><fpage>8940</fpage><lpage>8946</lpage><pub-id pub-id-type="doi">10.1039/D1OB01759D</pub-id><?supplied-pmid 34617948?><pub-id pub-id-type="pmid">34617948</pub-id></element-citation></ref><ref id="B36-marinedrugs-20-00341"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>J.J.</given-names></name>
<name><surname>Tang</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Nguyen</surname><given-names>D.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
</person-group><article-title>Broad-host-range expression reveals native and host regulatory elements that influence heterologous antibiotic production in Gram-negative bacteria</article-title><source>MBio</source><year>2017</year><volume>8</volume><fpage>e01291-17</fpage><pub-id pub-id-type="doi">10.1128/mBio.01291-17</pub-id><pub-id pub-id-type="pmid">28874475</pub-id></element-citation></ref><ref id="B37-marinedrugs-20-00341"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wenzel</surname><given-names>S.C.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
</person-group><article-title>Recent developments towards the heterologous expression of complex bacterial natural product biosynthetic pathways</article-title><source>Curr. Opin. Biotechnol.</source><year>2005</year><volume>16</volume><fpage>594</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2005.10.001</pub-id><pub-id pub-id-type="pmid">16226455</pub-id></element-citation></ref><ref id="B38-marinedrugs-20-00341"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Eppelmann</surname><given-names>K.</given-names></name>
<name><surname>Doekel</surname><given-names>S.</given-names></name>
<name><surname>Marahiel</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Engineered biosynthesis of the peptide antibiotic bacitracin in the surrogate host <italic toggle="yes">Bacillus subtilis</italic></article-title><source>J. Biol. Chem.</source><year>2001</year><volume>276</volume><fpage>34824</fpage><lpage>34831</lpage><pub-id pub-id-type="doi">10.1074/jbc.M104456200</pub-id><pub-id pub-id-type="pmid">11448966</pub-id></element-citation></ref><ref id="B39-marinedrugs-20-00341"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gustafsson</surname><given-names>C.</given-names></name>
<name><surname>Govindarajan</surname><given-names>S.</given-names></name>
<name><surname>Minshull</surname><given-names>J.</given-names></name>
</person-group><article-title>Codon bias and heterologous protein expression</article-title><source>Trends Biotechnol.</source><year>2004</year><volume>22</volume><fpage>346</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">15245907</pub-id></element-citation></ref><ref id="B40-marinedrugs-20-00341"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ongley</surname><given-names>S.E.</given-names></name>
<name><surname>Bian</surname><given-names>X.</given-names></name>
<name><surname>Neilan</surname><given-names>B.A.</given-names></name>
<name><surname>Muller</surname><given-names>R.</given-names></name>
</person-group><article-title>Recent advances in the heterologous expression of microbial natural product biosynthetic pathways</article-title><source>Nat. Prod. Rep.</source><year>2013</year><volume>30</volume><fpage>1121</fpage><lpage>1138</lpage><pub-id pub-id-type="doi">10.1039/c3np70034h</pub-id><pub-id pub-id-type="pmid">23832108</pub-id></element-citation></ref><ref id="B41-marinedrugs-20-00341"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>E.J.</given-names></name>
<name><surname>Lee</surname><given-names>J.H.</given-names></name>
<name><surname>Choi</surname><given-names>H.</given-names></name>
<name><surname>Pereira</surname><given-names>A.R.</given-names></name>
<name><surname>Ban</surname><given-names>Y.H.</given-names></name>
<name><surname>Yoo</surname><given-names>Y.J.</given-names></name>
<name><surname>Kim</surname><given-names>E.</given-names></name>
<name><surname>Park</surname><given-names>J.W.</given-names></name>
<name><surname>Sherman</surname><given-names>D.H.</given-names></name>
<name><surname>Gerwick</surname><given-names>W.H.</given-names></name>
</person-group><article-title>Heterologous production of 4-O-demethylbarbamide, a marine cyanobacterial natural product</article-title><source>Org. Lett.</source><year>2012</year><volume>14</volume><fpage>5824</fpage><lpage>5827</lpage><pub-id pub-id-type="doi">10.1021/ol302575h</pub-id><?supplied-pmid 23148802?><pub-id pub-id-type="pmid">23148802</pub-id></element-citation></ref><ref id="B42-marinedrugs-20-00341"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Salem</surname><given-names>S.M.</given-names></name>
<name><surname>Kancharla</surname><given-names>P.</given-names></name>
<name><surname>Florova</surname><given-names>G.</given-names></name>
<name><surname>Gupta</surname><given-names>S.</given-names></name>
<name><surname>Lu</surname><given-names>W.</given-names></name>
<name><surname>Reynolds</surname><given-names>K.A.</given-names></name>
</person-group><article-title>Elucidation of final steps of the marineosins biosynthetic pathway through identification and characterization of the corresponding gene cluster</article-title><source>J. Am. Chem. Soc.</source><year>2014</year><volume>136</volume><fpage>4565</fpage><lpage>4574</lpage><pub-id pub-id-type="doi">10.1021/ja411544w</pub-id><?supplied-pmid 24575817?><pub-id pub-id-type="pmid">24575817</pub-id></element-citation></ref><ref id="B43-marinedrugs-20-00341"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>T.</given-names></name>
<name><surname>Du</surname><given-names>Y.</given-names></name>
<name><surname>Cui</surname><given-names>Q.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Zhu</surname><given-names>W.</given-names></name>
<name><surname>Hong</surname><given-names>K.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
</person-group><article-title>Cloning, characterization and heterologous expression of the indolocarbazole biosynthetic gene cluster from marine-derived <italic toggle="yes">Streptomyces sanyensis</italic> FMA</article-title><source>Mar. Drugs</source><year>2013</year><volume>11</volume><fpage>466</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.3390/md11020466</pub-id><?supplied-pmid 23389092?><pub-id pub-id-type="pmid">23389092</pub-id></element-citation></ref><ref id="B44-marinedrugs-20-00341"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Tian</surname><given-names>X.</given-names></name>
<name><surname>Gu</surname><given-names>Y.</given-names></name>
<name><surname>Ju</surname><given-names>J.</given-names></name>
</person-group><article-title>Identification and Heterologous Expression of the Kendomycin B Biosynthetic Gene Cluster from <italic toggle="yes">Verrucosispora</italic> sp. SCSIO 07399</article-title><source>Mar. Drugs</source><year>2021</year><volume>19</volume><elocation-id>673</elocation-id><pub-id pub-id-type="doi">10.3390/md19120673</pub-id><pub-id pub-id-type="pmid">34940672</pub-id></element-citation></ref><ref id="B45-marinedrugs-20-00341"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oves-Costales</surname><given-names>D.</given-names></name>
<name><surname>Sanchez-Hidalgo</surname><given-names>M.</given-names></name>
<name><surname>Martin</surname><given-names>J.</given-names></name>
<name><surname>Genilloud</surname><given-names>O.</given-names></name>
</person-group><article-title>Identification, Cloning and Heterologous Expression of the Gene Cluster Directing RES-701-3, -4 Lasso Peptides Biosynthesis from a Marine <italic toggle="yes">Streptomyces</italic> Strain</article-title><source>Mar. Drugs</source><year>2020</year><volume>18</volume><elocation-id>238</elocation-id><pub-id pub-id-type="doi">10.3390/md18050238</pub-id></element-citation></ref><ref id="B46-marinedrugs-20-00341"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tan</surname><given-names>B.</given-names></name>
<name><surname>Chen</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Zhu</surname><given-names>Y.</given-names></name>
<name><surname>Khan</surname><given-names>I.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Zhang</surname><given-names>C.</given-names></name>
</person-group><article-title>Heterologous Expression Leads to Discovery of Diversified Lobophorin Analogues and a Flexible Glycosyltransferase</article-title><source>Org. Lett.</source><year>2020</year><volume>22</volume><fpage>1062</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.1021/acs.orglett.9b04597</pub-id><pub-id pub-id-type="pmid">31971807</pub-id></element-citation></ref><ref id="B47-marinedrugs-20-00341"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bonet</surname><given-names>B.</given-names></name>
<name><surname>Teufel</surname><given-names>R.</given-names></name>
<name><surname>Crusemann</surname><given-names>M.</given-names></name>
<name><surname>Ziemert</surname><given-names>N.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
</person-group><article-title>Direct capture and heterologous expression of <italic toggle="yes">Salinispora</italic> natural product genes for the biosynthesis of enterocin</article-title><source>J. Nat. Prod.</source><year>2015</year><volume>78</volume><fpage>539</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1021/np500664q</pub-id><pub-id pub-id-type="pmid">25382643</pub-id></element-citation></ref><ref id="B48-marinedrugs-20-00341"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yamanaka</surname><given-names>K.</given-names></name>
<name><surname>Reynolds</surname><given-names>K.A.</given-names></name>
<name><surname>Kersten</surname><given-names>R.D.</given-names></name>
<name><surname>Ryan</surname><given-names>K.S.</given-names></name>
<name><surname>Gonzalez</surname><given-names>D.J.</given-names></name>
<name><surname>Nizet</surname><given-names>V.</given-names></name>
<name><surname>Dorrestein</surname><given-names>P.C.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
</person-group><article-title>Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2014</year><volume>111</volume><fpage>1957</fpage><lpage>1962</lpage><pub-id pub-id-type="doi">10.1073/pnas.1319584111</pub-id><pub-id pub-id-type="pmid">24449899</pub-id></element-citation></ref><ref id="B49-marinedrugs-20-00341"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bauman</surname><given-names>K.D.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Murata</surname><given-names>K.</given-names></name>
<name><surname>Mantovani</surname><given-names>S.M.</given-names></name>
<name><surname>Dahesh</surname><given-names>S.</given-names></name>
<name><surname>Nizet</surname><given-names>V.</given-names></name>
<name><surname>Luhavaya</surname><given-names>H.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
</person-group><article-title>Refactoring the Cryptic Streptophenazine Biosynthetic Gene Cluster Unites Phenazine, Polyketide, and Nonribosomal Peptide Biochemistry</article-title><source>Cell. Chem. Biol.</source><year>2019</year><volume>26</volume><fpage>724</fpage><lpage>736.e7</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2019.02.004</pub-id><pub-id pub-id-type="pmid">30853419</pub-id></element-citation></ref><ref id="B50-marinedrugs-20-00341"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>C.</given-names></name>
<name><surname>Huang</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Zhu</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>C.</given-names></name>
</person-group><article-title>Heterologous Expression of Fluostatin Gene Cluster Leads to a Bioactive Heterodimer</article-title><source>Org. Lett.</source><year>2015</year><volume>17</volume><fpage>5324</fpage><lpage>5327</lpage><pub-id pub-id-type="doi">10.1021/acs.orglett.5b02683</pub-id><pub-id pub-id-type="pmid">26465097</pub-id></element-citation></ref><ref id="B51-marinedrugs-20-00341"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rodriguez Estevez</surname><given-names>M.</given-names></name>
<name><surname>Myronovskyi</surname><given-names>M.</given-names></name>
<name><surname>Gummerlich</surname><given-names>N.</given-names></name>
<name><surname>Nadmid</surname><given-names>S.</given-names></name>
<name><surname>Luzhetskyy</surname><given-names>A.</given-names></name>
</person-group><article-title>Heterologous Expression of the Nybomycin Gene Cluster from the Marine Strain <italic toggle="yes">Streptomyces albus</italic> subsp. chlorinus NRRL B-24108</article-title><source>Mar. Drugs</source><year>2018</year><volume>16</volume><elocation-id>435</elocation-id><pub-id pub-id-type="doi">10.3390/md16110435</pub-id><?supplied-pmid 30400361?><pub-id pub-id-type="pmid">30400361</pub-id></element-citation></ref><ref id="B52-marinedrugs-20-00341"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Myronovskyi</surname><given-names>M.</given-names></name>
<name><surname>Rosenkranzer</surname><given-names>B.</given-names></name>
<name><surname>Stierhof</surname><given-names>M.</given-names></name>
<name><surname>Petzke</surname><given-names>L.</given-names></name>
<name><surname>Seiser</surname><given-names>T.</given-names></name>
<name><surname>Luzhetskyy</surname><given-names>A.</given-names></name>
</person-group><article-title>Identification and Heterologous Expression of the Albucidin Gene Cluster from the Marine Strain <italic toggle="yes">Streptomyces Albus</italic> Subsp. Chlorinus NRRL B-24108</article-title><source>Microorganisms</source><year>2020</year><volume>8</volume><elocation-id>237</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms8020237</pub-id><?supplied-pmid 32050690?><pub-id pub-id-type="pmid">32050690</pub-id></element-citation></ref><ref id="B53-marinedrugs-20-00341"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Winter</surname><given-names>J.M.</given-names></name>
<name><surname>Moffitt</surname><given-names>M.C.</given-names></name>
<name><surname>Zazopoulos</surname><given-names>E.</given-names></name>
<name><surname>McAlpine</surname><given-names>J.B.</given-names></name>
<name><surname>Dorrestein</surname><given-names>P.C.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
</person-group><article-title>Molecular basis for chloronium-mediated meroterpene cyclization: Cloning, sequencing, and heterologous expression of the napyradiomycin biosynthetic gene cluster</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>16362</fpage><lpage>16368</lpage><pub-id pub-id-type="doi">10.1074/jbc.M611046200</pub-id><?supplied-pmid 17392281?><pub-id pub-id-type="pmid">17392281</pub-id></element-citation></ref><ref id="B54-marinedrugs-20-00341"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lombo</surname><given-names>F.</given-names></name>
<name><surname>Velasco</surname><given-names>A.</given-names></name>
<name><surname>Castro</surname><given-names>A.</given-names></name>
<name><surname>de la Calle</surname><given-names>F.</given-names></name>
<name><surname>Brana</surname><given-names>A.F.</given-names></name>
<name><surname>Sanchez-Puelles</surname><given-names>J.M.</given-names></name>
<name><surname>Mendez</surname><given-names>C.</given-names></name>
<name><surname>Salas</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Deciphering the biosynthesis pathway of the antitumor thiocoraline from a marine actinomycete and its expression in two <italic toggle="yes">streptomyces</italic> species</article-title><source>Chembiochem</source><year>2006</year><volume>7</volume><fpage>366</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1002/cbic.200500325</pub-id><pub-id pub-id-type="pmid">16408310</pub-id></element-citation></ref><ref id="B55-marinedrugs-20-00341"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>J.J.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
<name><surname>Tang</surname><given-names>X.</given-names></name>
</person-group><article-title>Engineering <italic toggle="yes">Salinispora tropica</italic> for heterologous expression of natural product biosynthetic gene clusters</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2018</year><volume>102</volume><fpage>8437</fpage><lpage>8446</lpage><pub-id pub-id-type="doi">10.1007/s00253-018-9283-z</pub-id><pub-id pub-id-type="pmid">30105571</pub-id></element-citation></ref><ref id="B56-marinedrugs-20-00341"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Yamanaka</surname><given-names>K.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Vlamakis</surname><given-names>H.</given-names></name>
<name><surname>Kolter</surname><given-names>R.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
<name><surname>Qian</surname><given-names>P.Y.</given-names></name>
</person-group><article-title>Directed natural product biosynthesis gene cluster capture and expression in the model bacterium <italic toggle="yes">Bacillus subtilis</italic></article-title><source>Sci. Rep.</source><year>2015</year><volume>5</volume><fpage>9383</fpage><pub-id pub-id-type="doi">10.1038/srep09383</pub-id><pub-id pub-id-type="pmid">25807046</pub-id></element-citation></ref><ref id="B57-marinedrugs-20-00341"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Taton</surname><given-names>A.</given-names></name>
<name><surname>Ecker</surname><given-names>A.</given-names></name>
<name><surname>Diaz</surname><given-names>B.</given-names></name>
<name><surname>Moss</surname><given-names>N.A.</given-names></name>
<name><surname>Anderson</surname><given-names>B.</given-names></name>
<name><surname>Reher</surname><given-names>R.</given-names></name>
<name><surname>Leao</surname><given-names>T.F.</given-names></name>
<name><surname>Simkovsky</surname><given-names>R.</given-names></name>
<name><surname>Dorrestein</surname><given-names>P.C.</given-names></name>
<name><surname>Gerwick</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Heterologous Expression of Cryptomaldamide in a Cyanobacterial Host</article-title><source>ACS. Synth. Biol.</source><year>2020</year><volume>9</volume><fpage>3364</fpage><lpage>3376</lpage><pub-id pub-id-type="doi">10.1021/acssynbio.0c00431</pub-id><pub-id pub-id-type="pmid">33180461</pub-id></element-citation></ref><ref id="B58-marinedrugs-20-00341"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Videau</surname><given-names>P.</given-names></name>
<name><surname>Wells</surname><given-names>K.N.</given-names></name>
<name><surname>Singh</surname><given-names>A.J.</given-names></name>
<name><surname>Gerwick</surname><given-names>W.H.</given-names></name>
<name><surname>Philmus</surname><given-names>B.</given-names></name>
</person-group><article-title>Assessment of <italic toggle="yes">Anabaena</italic> sp. Strain PCC 7120 as a Heterologous Expression Host for Cyanobacterial Natural Products: Production of Lyngbyatoxin A</article-title><source>ACS. Synth. Biol.</source><year>2016</year><volume>5</volume><fpage>978</fpage><lpage>988</lpage><pub-id pub-id-type="pmid">27176641</pub-id></element-citation></ref><ref id="B59-marinedrugs-20-00341"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Videau</surname><given-names>P.</given-names></name>
<name><surname>Wells</surname><given-names>K.N.</given-names></name>
<name><surname>Singh</surname><given-names>A.J.</given-names></name>
<name><surname>Eiting</surname><given-names>J.</given-names></name>
<name><surname>Proteau</surname><given-names>P.J.</given-names></name>
<name><surname>Philmus</surname><given-names>B.</given-names></name>
</person-group><article-title>Expanding the Natural Products Heterologous Expression Repertoire in the Model Cyanobacterium <italic toggle="yes">Anabaena</italic> sp. Strain PCC 7120: Production of Pendolmycin and Teleocidin B-4</article-title><source>ACS Synth. Biol.</source><year>2020</year><volume>9</volume><fpage>63</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1021/acssynbio.9b00334</pub-id><pub-id pub-id-type="pmid">31846576</pub-id></element-citation></ref><ref id="B60-marinedrugs-20-00341"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schmidt</surname><given-names>E.W.</given-names></name>
<name><surname>Nelson</surname><given-names>J.T.</given-names></name>
<name><surname>Rasko</surname><given-names>D.A.</given-names></name>
<name><surname>Sudek</surname><given-names>S.</given-names></name>
<name><surname>Eisen</surname><given-names>J.A.</given-names></name>
<name><surname>Haygood</surname><given-names>M.G.</given-names></name>
<name><surname>Ravel</surname><given-names>J.</given-names></name>
</person-group><article-title>Patellamide A and C biosynthesis by a microcin-like pathway in <italic toggle="yes">Prochloron didemni</italic>, the cyanobacterial symbiont of <italic toggle="yes">Lissoclinum patella</italic></article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>7315</fpage><lpage>7320</lpage><pub-id pub-id-type="pmid">15883371</pub-id></element-citation></ref><ref id="B61-marinedrugs-20-00341"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>H.</given-names></name>
<name><surname>Zhao</surname><given-names>S.</given-names></name>
<name><surname>Fan</surname><given-names>Y.</given-names></name>
<name><surname>Hu</surname><given-names>C.</given-names></name>
<name><surname>Lu</surname><given-names>W.</given-names></name>
<name><surname>Guo</surname><given-names>L.</given-names></name>
</person-group><article-title>Cloning and heterologous expression of a novel halo/alkali-stable multi-domain xylanase (XylM18) from a marine bacterium <italic toggle="yes">Marinimicrobium</italic> sp. strain LS-A18</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2019</year><volume>103</volume><fpage>8899</fpage><lpage>8909</lpage><pub-id pub-id-type="doi">10.1007/s00253-019-10140-6</pub-id><?supplied-pmid 31650195?><pub-id pub-id-type="pmid">31650195</pub-id></element-citation></ref><ref id="B62-marinedrugs-20-00341"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qin</surname><given-names>Y.</given-names></name>
<name><surname>Huang</surname><given-names>Z.</given-names></name>
<name><surname>Liu</surname><given-names>Z.</given-names></name>
</person-group><article-title>A novel cold-active and salt-tolerant alpha-amylase from marine bacterium <italic toggle="yes">Zunongwangia profunda</italic>: Molecular cloning, heterologous expression and biochemical characterization</article-title><source>Extremophiles</source><year>2014</year><volume>18</volume><fpage>271</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1007/s00792-013-0614-9</pub-id><?supplied-pmid 24318109?><pub-id pub-id-type="pmid">24318109</pub-id></element-citation></ref><ref id="B63-marinedrugs-20-00341"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Z.</given-names></name>
<name><surname>Li</surname><given-names>G.</given-names></name>
<name><surname>Mo</surname><given-names>Z.</given-names></name>
<name><surname>Mou</surname><given-names>H.</given-names></name>
</person-group><article-title>Molecular cloning, characterization, and heterologous expression of a new kappa-carrageenase gene from marine bacterium <italic toggle="yes">Zobellia</italic> sp. ZM-2</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2013</year><volume>97</volume><fpage>10057</fpage><lpage>10067</lpage><pub-id pub-id-type="doi">10.1007/s00253-013-5215-0</pub-id><?supplied-pmid 24196580?><pub-id pub-id-type="pmid">24196580</pub-id></element-citation></ref><ref id="B64-marinedrugs-20-00341"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garc&#x000ed;a-Fraga</surname><given-names>B.</given-names></name>
<name><surname>Da Silva</surname><given-names>A.F.</given-names></name>
<name><surname>L&#x000f3;pez-Seijas</surname><given-names>J.</given-names></name>
<name><surname>Sieiro</surname><given-names>C.</given-names></name>
</person-group><article-title>A novel family 19 chitinase from the marine-derived <italic toggle="yes">Pseudoalteromonas tunicata</italic> CCUG 44952T: Heterologous expression, characterization and antifungal activity</article-title><source>Biochem. Eng. J.</source><year>2015</year><volume>93</volume><fpage>84</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.bej.2014.09.014</pub-id></element-citation></ref><ref id="B65-marinedrugs-20-00341"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ongley</surname><given-names>S.E.</given-names></name>
<name><surname>Bian</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Chau</surname><given-names>R.</given-names></name>
<name><surname>Gerwick</surname><given-names>W.H.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
<name><surname>Neilan</surname><given-names>B.A.</given-names></name>
</person-group><article-title>High-titer heterologous production in <italic toggle="yes">E. coli</italic> of lyngbyatoxin, a protein kinase C activator from an uncultured marine cyanobacterium</article-title><source>ACS Chem. Biol.</source><year>2013</year><volume>8</volume><fpage>1888</fpage><lpage>1893</lpage><pub-id pub-id-type="doi">10.1021/cb400189j</pub-id><pub-id pub-id-type="pmid">23751865</pub-id></element-citation></ref><ref id="B66-marinedrugs-20-00341"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Anburajan</surname><given-names>L.</given-names></name>
<name><surname>Meena</surname><given-names>B.</given-names></name>
<name><surname>Raghavan</surname><given-names>R.V.</given-names></name>
<name><surname>Shridhar</surname><given-names>D.</given-names></name>
<name><surname>Joseph</surname><given-names>T.C.</given-names></name>
<name><surname>Vinithkumar</surname><given-names>N.V.</given-names></name>
<name><surname>Dharani</surname><given-names>G.</given-names></name>
<name><surname>Dheenan</surname><given-names>P.S.</given-names></name>
<name><surname>Kirubagaran</surname><given-names>R.</given-names></name>
</person-group><article-title>Heterologous expression, purification, and phylogenetic analysis of oil-degrading biosurfactant biosynthesis genes from the marine sponge-associated <italic toggle="yes">Bacillus licheniformis</italic> NIOT-06</article-title><source>Bioprocess Biosyst. Eng.</source><year>2015</year><volume>38</volume><fpage>1009</fpage><lpage>1018</lpage><pub-id pub-id-type="doi">10.1007/s00449-015-1359-x</pub-id><pub-id pub-id-type="pmid">25711393</pub-id></element-citation></ref><ref id="B67-marinedrugs-20-00341"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>X.</given-names></name>
<name><surname>Shen</surname><given-names>W.</given-names></name>
<name><surname>Gao</surname><given-names>Y.</given-names></name>
<name><surname>Cai</surname><given-names>M.</given-names></name>
<name><surname>Zhou</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Heterologous expression and purification of a marine alginate lyase in <italic toggle="yes">Escherichia coli</italic></article-title><source>Protein Expr. Purif.</source><year>2019</year><volume>153</volume><fpage>97</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/j.pep.2018.09.002</pub-id><pub-id pub-id-type="pmid">30201400</pub-id></element-citation></ref><ref id="B68-marinedrugs-20-00341"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ross</surname><given-names>A.C.</given-names></name>
<name><surname>Gulland</surname><given-names>L.E.</given-names></name>
<name><surname>Dorrestein</surname><given-names>P.C.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
</person-group><article-title>Targeted capture and heterologous expression of the <italic toggle="yes">Pseudoalteromonas alterochromide</italic> gene cluster in <italic toggle="yes">Escherichia coli</italic> represents a promising natural product exploratory platform</article-title><source>ACS. Synth. Biol.</source><year>2015</year><volume>4</volume><fpage>414</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1021/sb500280q</pub-id><pub-id pub-id-type="pmid">25140825</pub-id></element-citation></ref><ref id="B69-marinedrugs-20-00341"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thetsana</surname><given-names>C.</given-names></name>
<name><surname>Ijichi</surname><given-names>S.</given-names></name>
<name><surname>Kaweewan</surname><given-names>I.</given-names></name>
<name><surname>Nakagawa</surname><given-names>H.</given-names></name>
<name><surname>Kodani</surname><given-names>S.</given-names></name>
</person-group><article-title>Heterologous expression of a cryptic gene cluster from a marine proteobacterium <italic toggle="yes">Thalassomonas actiniarum</italic> affords new lanthipeptides thalassomonasins A and B</article-title><source>J. Appl. Microbiol.</source><year>2022</year><volume>132</volume><fpage>3629</fpage><lpage>3639</lpage><pub-id pub-id-type="doi">10.1111/jam.15491</pub-id><pub-id pub-id-type="pmid">35157343</pub-id></element-citation></ref><ref id="B70-marinedrugs-20-00341"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kaweewan</surname><given-names>I.</given-names></name>
<name><surname>Nakagawa</surname><given-names>H.</given-names></name>
<name><surname>Kodani</surname><given-names>S.</given-names></name>
</person-group><article-title>Heterologous expression of a cryptic gene cluster from <italic toggle="yes">Marinomonas fungiae</italic> affords a novel tricyclic peptide marinomonasin</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2021</year><volume>105</volume><fpage>7241</fpage><lpage>7250</lpage><pub-id pub-id-type="pmid">34480236</pub-id></element-citation></ref><ref id="B71-marinedrugs-20-00341"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Su</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>F.</given-names></name>
<name><surname>Sun</surname><given-names>W.</given-names></name>
<name><surname>Karuppiah</surname><given-names>V.</given-names></name>
<name><surname>Zhang</surname><given-names>G.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Jiang</surname><given-names>Q.</given-names></name>
</person-group><article-title>A new alkaline lipase obtained from the metagenome of marine sponge <italic toggle="yes">Ircinia</italic> sp.</article-title><source>World J. Microbiol. Biotechnol.</source><year>2015</year><volume>31</volume><fpage>1093</fpage><lpage>1102</lpage><pub-id pub-id-type="doi">10.1007/s11274-015-1859-5</pub-id><?supplied-pmid 25921581?><pub-id pub-id-type="pmid">25921581</pub-id></element-citation></ref><ref id="B72-marinedrugs-20-00341"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pushpanathan</surname><given-names>M.</given-names></name>
<name><surname>Rajendhran</surname><given-names>J.</given-names></name>
<name><surname>Jayashree</surname><given-names>S.</given-names></name>
<name><surname>Sundarakrishnan</surname><given-names>B.</given-names></name>
<name><surname>Jayachandran</surname><given-names>S.</given-names></name>
<name><surname>Gunasekaran</surname><given-names>P.</given-names></name>
</person-group><article-title>Identification of a novel antifungal peptide with chitin-binding property from marine metagenome</article-title><source>Protein Pept. Lett.</source><year>2012</year><volume>19</volume><fpage>1289</fpage><lpage>1296</lpage><pub-id pub-id-type="doi">10.2174/092986612803521620</pub-id><?supplied-pmid 22670672?><pub-id pub-id-type="pmid">22670672</pub-id></element-citation></ref><ref id="B73-marinedrugs-20-00341"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fujita</surname><given-names>M.J.</given-names></name>
<name><surname>Sakai</surname><given-names>R.</given-names></name>
</person-group><article-title>Production of avaroferrin and putrebactin by heterologous expression of a deep-sea metagenomic DNA</article-title><source>Mar. Drugs</source><year>2014</year><volume>12</volume><fpage>4799</fpage><lpage>4809</lpage><pub-id pub-id-type="doi">10.3390/md12094799</pub-id><?supplied-pmid 25222668?><pub-id pub-id-type="pmid">25222668</pub-id></element-citation></ref><ref id="B74-marinedrugs-20-00341"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fujita</surname><given-names>M.J.</given-names></name>
<name><surname>Kimura</surname><given-names>N.</given-names></name>
<name><surname>Yokose</surname><given-names>H.</given-names></name>
<name><surname>Otsuka</surname><given-names>M.</given-names></name>
</person-group><article-title>Heterologous production of bisucaberin using a biosynthetic gene cluster cloned from a deep sea metagenome</article-title><source>Mol. Biosyst.</source><year>2012</year><volume>8</volume><fpage>482</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1039/C1MB05431G</pub-id><pub-id pub-id-type="pmid">22051782</pub-id></element-citation></ref><ref id="B75-marinedrugs-20-00341"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Selvin</surname><given-names>J.</given-names></name>
<name><surname>Kennedy</surname><given-names>J.</given-names></name>
<name><surname>Lejon</surname><given-names>D.P.</given-names></name>
<name><surname>Kiran</surname><given-names>G.S.</given-names></name>
<name><surname>Dobson</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Isolation identification and biochemical characterization of a novel halo-tolerant lipase from the metagenome of the marine sponge <italic toggle="yes">Haliclona simulans</italic></article-title><source>Microbial. Cell Factories</source><year>2012</year><volume>11</volume><fpage>72</fpage><pub-id pub-id-type="doi">10.1186/1475-2859-11-72</pub-id><pub-id pub-id-type="pmid">22657530</pub-id></element-citation></ref><ref id="B76-marinedrugs-20-00341"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abe</surname><given-names>T.</given-names></name>
<name><surname>Kukita</surname><given-names>A.</given-names></name>
<name><surname>Akiyama</surname><given-names>K.</given-names></name>
<name><surname>Naito</surname><given-names>T.</given-names></name>
<name><surname>Uemura</surname><given-names>D.</given-names></name>
</person-group><article-title>Isolation and Structure of a Novel Biindole Pigment Substituted with an Ethyl Group from a Metagenomic Library Derived from the Marine Sponge <italic toggle="yes">Halichondria okadai</italic></article-title><source>Chem. Lett.</source><year>2012</year><volume>41</volume><fpage>728</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1246/cl.2012.728</pub-id></element-citation></ref><ref id="B77-marinedrugs-20-00341"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gao</surname><given-names>W.</given-names></name>
<name><surname>Wu</surname><given-names>K.</given-names></name>
<name><surname>Chen</surname><given-names>L.</given-names></name>
<name><surname>Fan</surname><given-names>H.</given-names></name>
<name><surname>Zhao</surname><given-names>Z.</given-names></name>
<name><surname>Gao</surname><given-names>B.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Wei</surname><given-names>D.</given-names></name>
</person-group><article-title>A novel esterase from a marine mud metagenomic library for biocatalytic synthesis of short-chain flavor esters</article-title><source>Microb. Cell. Fact.</source><year>2016</year><volume>15</volume><fpage>41</fpage><pub-id pub-id-type="doi">10.1186/s12934-016-0435-5</pub-id><pub-id pub-id-type="pmid">26892801</pub-id></element-citation></ref><ref id="B78-marinedrugs-20-00341"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>H.</given-names></name>
<name><surname>Yang</surname><given-names>G.</given-names></name>
<name><surname>Cao</surname><given-names>R.</given-names></name>
<name><surname>Mao</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>Q.</given-names></name>
</person-group><article-title>Expression and characterization of a novel glycoside hydrolase family 46 chitosanase identified from marine mud metagenome</article-title><source>Int. J. Biol. Macromol.</source><year>2020</year><volume>159</volume><fpage>904</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.05.147</pub-id><pub-id pub-id-type="pmid">32446901</pub-id></element-citation></ref><ref id="B79-marinedrugs-20-00341"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fang</surname><given-names>Z.</given-names></name>
<name><surname>Li</surname><given-names>T.</given-names></name>
<name><surname>Wang</surname><given-names>Q.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Peng</surname><given-names>H.</given-names></name>
<name><surname>Fang</surname><given-names>W.</given-names></name>
<name><surname>Hong</surname><given-names>Y.</given-names></name>
<name><surname>Ge</surname><given-names>H.</given-names></name>
<name><surname>Xiao</surname><given-names>Y.</given-names></name>
</person-group><article-title>A bacterial laccase from marine microbial metagenome exhibiting chloride tolerance and dye decolorization ability</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2011</year><volume>89</volume><fpage>1103</fpage><lpage>1110</lpage><pub-id pub-id-type="doi">10.1007/s00253-010-2934-3</pub-id><pub-id pub-id-type="pmid">20963410</pub-id></element-citation></ref><ref id="B80-marinedrugs-20-00341"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fujita</surname><given-names>M.J.</given-names></name>
<name><surname>Sakai</surname><given-names>R.</given-names></name>
</person-group><article-title>Heterologous production of desferrioxamines with a fusion biosynthetic gene cluster</article-title><source>Biosci. Biotechnol. Biochem.</source><year>2013</year><volume>77</volume><fpage>2467</fpage><lpage>2472</lpage><pub-id pub-id-type="doi">10.1271/bbb.130597</pub-id><pub-id pub-id-type="pmid">24317070</pub-id></element-citation></ref><ref id="B81-marinedrugs-20-00341"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>Y.</given-names></name>
<name><surname>Feng</surname><given-names>Z.</given-names></name>
<name><surname>Tomura</surname><given-names>T.</given-names></name>
<name><surname>Suzuki</surname><given-names>A.</given-names></name>
<name><surname>Miyano</surname><given-names>S.</given-names></name>
<name><surname>Tsuge</surname><given-names>T.</given-names></name>
<name><surname>Mori</surname><given-names>H.</given-names></name>
<name><surname>Suh</surname><given-names>J.W.</given-names></name>
<name><surname>Iizuka</surname><given-names>T.</given-names></name>
<name><surname>Fudou</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>Heterologous Production of the Marine Myxobacterial Antibiotic Haliangicin and Its Unnatural Analogues Generated by Engineering of the Biochemical Pathway</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>22091</fpage><pub-id pub-id-type="doi">10.1038/srep22091</pub-id><?supplied-pmid 26915413?><pub-id pub-id-type="pmid">26915413</pub-id></element-citation></ref><ref id="B82-marinedrugs-20-00341"><label>82.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>A.</given-names></name>
</person-group><source>Heterologous Expression of Beauvericin in Aspergillus nidulans</source><publisher-name>Anhui University</publisher-name><publisher-loc>Hefei, China</publisher-loc><year>2016</year></element-citation></ref><ref id="B83-marinedrugs-20-00341"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maeda</surname><given-names>Y.</given-names></name>
<name><surname>Tsuru</surname><given-names>Y.</given-names></name>
<name><surname>Matsumoto</surname><given-names>N.</given-names></name>
<name><surname>Nonoyama</surname><given-names>T.</given-names></name>
<name><surname>Yoshino</surname><given-names>T.</given-names></name>
<name><surname>Matsumoto</surname><given-names>M.</given-names></name>
<name><surname>Tanaka</surname><given-names>T.</given-names></name>
</person-group><article-title>Prostaglandin production by the microalga with heterologous expression of cyclooxygenase</article-title><source>Biotechnol. Bioeng.</source><year>2021</year><volume>118</volume><fpage>2734</fpage><lpage>2743</lpage><pub-id pub-id-type="doi">10.1002/bit.27792</pub-id><?supplied-pmid 33851720?><pub-id pub-id-type="pmid">33851720</pub-id></element-citation></ref><ref id="B84-marinedrugs-20-00341"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Angov</surname><given-names>E.</given-names></name>
<name><surname>Hillier</surname><given-names>C.J.</given-names></name>
<name><surname>Kincaid</surname><given-names>R.L.</given-names></name>
<name><surname>Lyon</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Heterologous protein expression is enhanced by harmonizing the codon usage frequencies of the target gene with those of the expression host</article-title><source>PLoS ONE</source><year>2008</year><volume>3</volume><elocation-id>e2189</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0002189</pub-id><?supplied-pmid 18478103?><pub-id pub-id-type="pmid">18478103</pub-id></element-citation></ref><ref id="B85-marinedrugs-20-00341"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gao</surname><given-names>X.</given-names></name>
<name><surname>Wang</surname><given-names>P.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Engineered polyketide biosynthesis and biocatalysis in <italic toggle="yes">Escherichia coli</italic></article-title><source>Appl. Microbiol. Biotechnol.</source><year>2010</year><volume>88</volume><fpage>1233</fpage><lpage>1242</lpage><pub-id pub-id-type="doi">10.1007/s00253-010-2860-4</pub-id><?supplied-pmid 20853106?><pub-id pub-id-type="pmid">20853106</pub-id></element-citation></ref><ref id="B86-marinedrugs-20-00341"><label>86.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Fang</surname><given-names>L.</given-names></name>
<name><surname>Osburne</surname><given-names>M.S.</given-names></name>
<name><surname>Pfeifer</surname><given-names>B.A.</given-names></name>
</person-group><article-title>The continuing development of <italic toggle="yes">E. coli</italic> as a heterologous host for complex natural product biosynthesis</article-title><source>Nonribosomal Peptide and Polyketide Biosynthesis</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2016</year><fpage>121</fpage><lpage>134</lpage></element-citation></ref><ref id="B87-marinedrugs-20-00341"><label>87.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Fang</surname><given-names>L.</given-names></name>
<name><surname>Zhang</surname><given-names>G.</given-names></name>
<name><surname>Pfeifer</surname><given-names>B.A.</given-names></name>
</person-group><article-title>Engineering of E. coli for Heterologous Expression of Secondary Metabolite Biosynthesis Pathways Recovered from Metagenomics Libraries</article-title><source>Functional Metagenomics: Tools and Applications</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2017</year><fpage>45</fpage><lpage>63</lpage></element-citation></ref><ref id="B88-marinedrugs-20-00341"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Long</surname><given-names>P.F.</given-names></name>
<name><surname>Dunlap</surname><given-names>W.C.</given-names></name>
<name><surname>Battershill</surname><given-names>C.N.</given-names></name>
<name><surname>Jaspars</surname><given-names>M.</given-names></name>
</person-group><article-title>Shotgun cloning and heterologous expression of the patellamide gene cluster as a strategy to achieving sustained metabolite production</article-title><source>Chembiochem</source><year>2005</year><volume>6</volume><fpage>1760</fpage><lpage>1765</lpage><pub-id pub-id-type="doi">10.1002/cbic.200500210</pub-id><?supplied-pmid 15988766?><pub-id pub-id-type="pmid">15988766</pub-id></element-citation></ref><ref id="B89-marinedrugs-20-00341"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dittmann</surname><given-names>E.</given-names></name>
<name><surname>Gugger</surname><given-names>M.</given-names></name>
<name><surname>Sivonen</surname><given-names>K.</given-names></name>
<name><surname>Fewer</surname><given-names>D.P.</given-names></name>
</person-group><article-title>Natural product biosynthetic diversity and comparative genomics of the cyanobacteria</article-title><source>Trends Microbiol.</source><year>2015</year><volume>23</volume><fpage>642</fpage><lpage>652</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2015.07.008</pub-id><pub-id pub-id-type="pmid">26433696</pub-id></element-citation></ref><ref id="B90-marinedrugs-20-00341"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gerwick</surname><given-names>W.H.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
</person-group><article-title>Lessons from the past and charting the future of marine natural products drug discovery and chemical biology</article-title><source>Chem. Biol.</source><year>2012</year><volume>19</volume><fpage>85</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2011.12.014</pub-id><pub-id pub-id-type="pmid">22284357</pub-id></element-citation></ref><ref id="B91-marinedrugs-20-00341"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gerwick</surname><given-names>W.H.</given-names></name>
<name><surname>Coates</surname><given-names>R.C.</given-names></name>
<name><surname>Engene</surname><given-names>N.</given-names></name>
<name><surname>Gerwick</surname><given-names>L.</given-names></name>
<name><surname>Grindberg</surname><given-names>R.V.</given-names></name>
<name><surname>Jones</surname><given-names>A.C.</given-names></name>
<name><surname>Sorrels</surname><given-names>C.M.</given-names></name>
</person-group><article-title>Giant marine cyanobacteria produce exciting potential pharmaceuticals</article-title><source>Microbe-ASM</source><year>2008</year><volume>3</volume><fpage>277</fpage><pub-id pub-id-type="doi">10.1128/microbe.3.277.1</pub-id></element-citation></ref><ref id="B92-marinedrugs-20-00341"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Balskus</surname><given-names>E.P.</given-names></name>
<name><surname>Walsh</surname><given-names>C.T.</given-names></name>
</person-group><article-title>The genetic and molecular basis for sunscreen biosynthesis in cyanobacteria</article-title><source>Science</source><year>2010</year><volume>329</volume><fpage>1653</fpage><lpage>1656</lpage><pub-id pub-id-type="doi">10.1126/science.1193637</pub-id><pub-id pub-id-type="pmid">20813918</pub-id></element-citation></ref><ref id="B93-marinedrugs-20-00341"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Newman</surname><given-names>D.J.</given-names></name>
<name><surname>Cragg</surname><given-names>G.M.</given-names></name>
</person-group><article-title>Natural products as sources of new drugs from 1981 to 2014</article-title><source>J. Nat. Prod.</source><year>2016</year><volume>79</volume><fpage>629</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b01055</pub-id><pub-id pub-id-type="pmid">26852623</pub-id></element-citation></ref><ref id="B94-marinedrugs-20-00341"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kleigrewe</surname><given-names>K.</given-names></name>
<name><surname>Gerwick</surname><given-names>L.</given-names></name>
<name><surname>Sherman</surname><given-names>D.H.</given-names></name>
<name><surname>Gerwick</surname><given-names>W.H.</given-names></name>
</person-group><article-title>Unique marine derived cyanobacterial biosynthetic genes for chemical diversity</article-title><source>Nat. Prod. Rep.</source><year>2016</year><volume>33</volume><fpage>348</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1039/C5NP00097A</pub-id><?supplied-pmid 26758451?><pub-id pub-id-type="pmid">26758451</pub-id></element-citation></ref><ref id="B95-marinedrugs-20-00341"><label>95.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Choi</surname><given-names>H.</given-names></name>
<name><surname>Pereira</surname><given-names>A.</given-names></name>
<name><surname>Gerwick</surname><given-names>W.</given-names></name>
</person-group><article-title>The chemistry of marine algae and cyanobacteria</article-title><source>Handbook of Marine Natural Products</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2012</year><fpage>55</fpage><lpage>152</lpage></element-citation></ref><ref id="B96-marinedrugs-20-00341"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baltz</surname><given-names>R.H.</given-names></name>
</person-group><article-title>Renaissance in antibacterial discovery from actinomycetes</article-title><source>Curr. Opin. Pharmacol.</source><year>2008</year><volume>8</volume><fpage>557</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1016/j.coph.2008.04.008</pub-id><?supplied-pmid 18524678?><pub-id pub-id-type="pmid">18524678</pub-id></element-citation></ref><ref id="B97-marinedrugs-20-00341"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zerikly</surname><given-names>M.</given-names></name>
<name><surname>Challis</surname><given-names>G.L.</given-names></name>
</person-group><article-title>Strategies for the discovery of new natural products by genome mining</article-title><source>ChemBioChem</source><year>2009</year><volume>10</volume><fpage>625</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1002/cbic.200800389</pub-id><?supplied-pmid 19165837?><pub-id pub-id-type="pmid">19165837</pub-id></element-citation></ref><ref id="B98-marinedrugs-20-00341"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gong</surname><given-names>B.</given-names></name>
<name><surname>Chen</surname><given-names>S.</given-names></name>
<name><surname>Lan</surname><given-names>W.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Zhu</surname><given-names>X.</given-names></name>
</person-group><article-title>Antibacterial and antitumor potential of actinomycetes isolated. from mangrove soil in the Maowei Sea of the southern coast of China. Iran</article-title><source>J. Pharm. Sci. IJPR</source><year>2018</year><volume>17</volume><fpage>1339</fpage></element-citation></ref><ref id="B99-marinedrugs-20-00341"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Amelia-Yap</surname><given-names>Z.H.</given-names></name>
<name><surname>Azman</surname><given-names>A.S.</given-names></name>
<name><surname>AbuBakar</surname><given-names>S.</given-names></name>
<name><surname>Low</surname><given-names>V.L.</given-names></name>
</person-group><article-title><italic toggle="yes">Streptomyces</italic> derivatives as an insecticide: Current perspectives, challenges and future research needs for mosquito control</article-title><source>Acta Trop.</source><year>2022</year><volume>229</volume><fpage>106381</fpage><pub-id pub-id-type="doi">10.1016/j.actatropica.2022.106381</pub-id><pub-id pub-id-type="pmid">35183537</pub-id></element-citation></ref><ref id="B100-marinedrugs-20-00341"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hahn</surname><given-names>D.R.</given-names></name>
<name><surname>Graupner</surname><given-names>P.R.</given-names></name>
<name><surname>Chapin</surname><given-names>E.</given-names></name>
<name><surname>Gray</surname><given-names>J.</given-names></name>
<name><surname>Heim</surname><given-names>D.</given-names></name>
<name><surname>Gilbert</surname><given-names>J.R.</given-names></name>
<name><surname>Gerwick</surname><given-names>B.C.</given-names></name>
</person-group><article-title>Albucidin: A novel bleaching herbicide from <italic toggle="yes">Streptomyces albus</italic> subsp. chlorinus NRRL B-24108</article-title><source>J. Antibiot.</source><year>2009</year><volume>62</volume><fpage>191</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1038/ja.2009.11</pub-id></element-citation></ref><ref id="B101-marinedrugs-20-00341"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gomez-Escribano</surname><given-names>J.P.</given-names></name>
<name><surname>Bibb</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Engineering <italic toggle="yes">Streptomyces coelicolor</italic> for heterologous expression of secondary metabolite gene clusters</article-title><source>Microb. Biotechnol.</source><year>2011</year><volume>4</volume><fpage>207</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1111/j.1751-7915.2010.00219.x</pub-id><pub-id pub-id-type="pmid">21342466</pub-id></element-citation></ref><ref id="B102-marinedrugs-20-00341"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moszer</surname><given-names>I.</given-names></name>
<name><surname>Jones</surname><given-names>L.M.</given-names></name>
<name><surname>Moreira</surname><given-names>S.</given-names></name>
<name><surname>Fabry</surname><given-names>C.</given-names></name>
<name><surname>Danchin</surname><given-names>A.</given-names></name>
</person-group><article-title>SubtiList: The reference database for the <italic toggle="yes">Bacillus subtilis</italic> genome</article-title><source>Nucleic Acids Res.</source><year>2002</year><volume>30</volume><fpage>62</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1093/nar/30.1.62</pub-id><pub-id pub-id-type="pmid">11752255</pub-id></element-citation></ref><ref id="B103-marinedrugs-20-00341"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nielsen</surname><given-names>J.</given-names></name>
</person-group><article-title>Yeast cell factories on the horizon</article-title><source>Science</source><year>2015</year><volume>349</volume><fpage>1050</fpage><lpage>1051</lpage><pub-id pub-id-type="doi">10.1126/science.aad2081</pub-id><pub-id pub-id-type="pmid">26339012</pub-id></element-citation></ref><ref id="B104-marinedrugs-20-00341"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tsunematsu</surname><given-names>Y.</given-names></name>
<name><surname>Ishiuchi</surname><given-names>K.</given-names></name>
<name><surname>Hotta</surname><given-names>K.</given-names></name>
<name><surname>Watanabe</surname><given-names>K.</given-names></name>
</person-group><article-title>Yeast-based genome mining, production and mechanistic studies of the biosynthesis of fungal polyketide and peptide natural products</article-title><source>Nat. Prod. Rep.</source><year>2013</year><volume>30</volume><fpage>1139</fpage><lpage>1149</lpage><pub-id pub-id-type="doi">10.1039/c3np70037b</pub-id><pub-id pub-id-type="pmid">23824111</pub-id></element-citation></ref><ref id="B105-marinedrugs-20-00341"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vassaux</surname><given-names>A.</given-names></name>
<name><surname>Meunier</surname><given-names>L.</given-names></name>
<name><surname>Vandenbol</surname><given-names>M.</given-names></name>
<name><surname>Baurain</surname><given-names>D.</given-names></name>
<name><surname>Fickers</surname><given-names>P.</given-names></name>
<name><surname>Jacques</surname><given-names>P.</given-names></name>
<name><surname>Leclere</surname><given-names>V.</given-names></name>
</person-group><article-title>Nonribosomal peptides in fungal cell factories: From genome mining to optimized heterologous production</article-title><source>Biotechnol. Adv.</source><year>2019</year><volume>37</volume><fpage>107449</fpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2019.107449</pub-id><?supplied-pmid 31518630?><pub-id pub-id-type="pmid">31518630</pub-id></element-citation></ref><ref id="B106-marinedrugs-20-00341"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lazarus</surname><given-names>C.M.</given-names></name>
<name><surname>Williams</surname><given-names>K.</given-names></name>
<name><surname>Bailey</surname><given-names>A.M.</given-names></name>
</person-group><article-title>Reconstructing fungal natural product biosynthetic pathways</article-title><source>Nat. Prod. Rep.</source><year>2014</year><volume>31</volume><fpage>1339</fpage><lpage>1347</lpage><pub-id pub-id-type="doi">10.1039/C4NP00084F</pub-id><?supplied-pmid 25140842?><pub-id pub-id-type="pmid">25140842</pub-id></element-citation></ref><ref id="B107-marinedrugs-20-00341"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
</person-group><article-title>Recent advances in understanding and engineering polyketide synthesis</article-title><source>F1000Research</source><year>2016</year><volume>5</volume><fpage>F1000 Faculty Rev-208</fpage><pub-id pub-id-type="doi">10.12688/f1000research.7326.1</pub-id></element-citation></ref><ref id="B108-marinedrugs-20-00341"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Silber</surname><given-names>J.</given-names></name>
<name><surname>Kramer</surname><given-names>A.</given-names></name>
<name><surname>Labes</surname><given-names>A.</given-names></name>
<name><surname>Tasdemir</surname><given-names>D.</given-names></name>
</person-group><article-title>From Discovery to Production: Biotechnology of Marine Fungi for the Production of New Antibiotics</article-title><source>Mar Drugs</source><year>2016</year><volume>14</volume><elocation-id>137</elocation-id><pub-id pub-id-type="doi">10.3390/md14070137</pub-id><?supplied-pmid 27455283?><pub-id pub-id-type="pmid">27455283</pub-id></element-citation></ref><ref id="B109-marinedrugs-20-00341"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Papaefthimiou</surname><given-names>D.</given-names></name>
<name><surname>Diretto</surname><given-names>G.</given-names></name>
<name><surname>Demurtas</surname><given-names>O.C.</given-names></name>
<name><surname>Mini</surname><given-names>P.</given-names></name>
<name><surname>Ferrante</surname><given-names>P.</given-names></name>
<name><surname>Giuliano</surname><given-names>G.</given-names></name>
<name><surname>Kanellis</surname><given-names>A.K.</given-names></name>
</person-group><article-title>Heterologous production of labdane-type diterpenes in the green alga <italic toggle="yes">Chlamydomonas reinhardtii</italic></article-title><source>Phytochemistry</source><year>2019</year><volume>167</volume><fpage>112082</fpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2019.112082</pub-id><?supplied-pmid 31421542?><pub-id pub-id-type="pmid">31421542</pub-id></element-citation></ref><ref id="B110-marinedrugs-20-00341"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lauersen</surname><given-names>K.J.</given-names></name>
<name><surname>Baier</surname><given-names>T.</given-names></name>
<name><surname>Wichmann</surname><given-names>J.</given-names></name>
<name><surname>Wordenweber</surname><given-names>R.</given-names></name>
<name><surname>Mussgnug</surname><given-names>J.H.</given-names></name>
<name><surname>Hubner</surname><given-names>W.</given-names></name>
<name><surname>Huser</surname><given-names>T.</given-names></name>
<name><surname>Kruse</surname><given-names>O.</given-names></name>
</person-group><article-title>Efficient phototrophic production of a high-value sesquiterpenoid from the eukaryotic microalga <italic toggle="yes">Chlamydomonas reinhardtii</italic></article-title><source>Metab. Eng.</source><year>2016</year><volume>38</volume><fpage>331</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/j.ymben.2016.07.013</pub-id><pub-id pub-id-type="pmid">27474353</pub-id></element-citation></ref><ref id="B111-marinedrugs-20-00341"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fabris</surname><given-names>M.</given-names></name>
<name><surname>George</surname><given-names>J.</given-names></name>
<name><surname>Kuzhiumparambil</surname><given-names>U.</given-names></name>
<name><surname>Lawson</surname><given-names>C.A.</given-names></name>
<name><surname>Jaramillo-Madrid</surname><given-names>A.C.</given-names></name>
<name><surname>Abbriano</surname><given-names>R.M.</given-names></name>
<name><surname>Vickers</surname><given-names>C.E.</given-names></name>
<name><surname>Ralph</surname><given-names>P.</given-names></name>
</person-group><article-title>Extrachromosomal Genetic Engineering of the Marine Diatom <italic toggle="yes">Phaeodactylum tricornutum</italic> Enables the Heterologous Production of Monoterpenoids</article-title><source>ACS. Synth. Biol.</source><year>2020</year><volume>9</volume><fpage>598</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1021/acssynbio.9b00455</pub-id><pub-id pub-id-type="pmid">32032487</pub-id></element-citation></ref><ref id="B112-marinedrugs-20-00341"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kouprina</surname><given-names>N.</given-names></name>
<name><surname>Larionov</surname><given-names>V.</given-names></name>
</person-group><article-title>TAR cloning: Insights into gene function, long-range haplotypes and genome structure and evolution</article-title><source>Nat. Rev. Genet.</source><year>2006</year><volume>7</volume><fpage>805</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1038/nrg1943</pub-id><pub-id pub-id-type="pmid">16983376</pub-id></element-citation></ref><ref id="B113-marinedrugs-20-00341"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kouprina</surname><given-names>N.</given-names></name>
<name><surname>Larionov</surname><given-names>V.</given-names></name>
</person-group><article-title>Selective isolation of genomic loci from complex genomes by transformation-associated recombination cloning in the yeast <italic toggle="yes">Saccharomyces cerevisiae</italic></article-title><source>Nat. Protoc.</source><year>2008</year><volume>3</volume><fpage>371</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.5</pub-id><pub-id pub-id-type="pmid">18323808</pub-id></element-citation></ref><ref id="B114-marinedrugs-20-00341"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murphy</surname><given-names>K.C.</given-names></name>
</person-group><article-title>Use of bacteriophage &#x003bb; recombination functions to promote gene replacement in <italic toggle="yes">Escherichia coli</italic></article-title><source>J. Bacteriol.</source><year>1998</year><volume>180</volume><fpage>2063</fpage><lpage>2071</lpage><pub-id pub-id-type="doi">10.1128/JB.180.8.2063-2071.1998</pub-id><pub-id pub-id-type="pmid">9555887</pub-id></element-citation></ref><ref id="B115-marinedrugs-20-00341"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Sarov</surname><given-names>M.</given-names></name>
<name><surname>Rientjes</surname><given-names>J.</given-names></name>
<name><surname>Hu</surname><given-names>J.</given-names></name>
<name><surname>Hollak</surname><given-names>H.</given-names></name>
<name><surname>Kranz</surname><given-names>H.</given-names></name>
<name><surname>Xie</surname><given-names>Y.</given-names></name>
<name><surname>Stewart</surname><given-names>A.F.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
</person-group><article-title>An improved recombineering approach by adding RecA to &#x003bb; red recombination</article-title><source>Mol. Biotechnol.</source><year>2006</year><volume>32</volume><fpage>43</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1385/MB:32:1:043</pub-id><pub-id pub-id-type="pmid">16382181</pub-id></element-citation></ref><ref id="B116-marinedrugs-20-00341"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Colloms</surname><given-names>S.D.</given-names></name>
<name><surname>Merrick</surname><given-names>C.A.</given-names></name>
<name><surname>Olorunniji</surname><given-names>F.J.</given-names></name>
<name><surname>Stark</surname><given-names>W.M.</given-names></name>
<name><surname>Smith</surname><given-names>M.C.</given-names></name>
<name><surname>Osbourn</surname><given-names>A.</given-names></name>
<name><surname>Keasling</surname><given-names>J.D.</given-names></name>
<name><surname>Rosser</surname><given-names>S.J.</given-names></name>
</person-group><article-title>Rapid metabolic pathway assembly and modification using serine integrase site-specific recombination</article-title><source>Nucleic Acids Res.</source><year>2014</year><volume>42</volume><fpage>e23</fpage><pub-id pub-id-type="doi">10.1093/nar/gkt1101</pub-id><?supplied-pmid 24225316?><pub-id pub-id-type="pmid">24225316</pub-id></element-citation></ref><ref id="B117-marinedrugs-20-00341"><label>117.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>DiLella</surname><given-names>A.G.</given-names></name>
<name><surname>Woo</surname><given-names>S.L.</given-names></name>
</person-group><article-title>[18] Cloning large segments of genomic DNA using cosmid vectors</article-title><source>Methods in Enzymology</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>1987</year><volume>Volume 152</volume><fpage>199</fpage><lpage>212</lpage></element-citation></ref><ref id="B118-marinedrugs-20-00341"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>U.-J.</given-names></name>
<name><surname>Shizuya</surname><given-names>H.</given-names></name>
<name><surname>de Jong</surname><given-names>P.J.</given-names></name>
<name><surname>Birren</surname><given-names>B.</given-names></name>
<name><surname>Simon</surname><given-names>M.I.</given-names></name>
</person-group><article-title>Stable propagation of cosmid sized human DNA inserts in an F factor based vector</article-title><source>Nucleic Acids Res.</source><year>1992</year><volume>20</volume><fpage>1083</fpage><lpage>1085</lpage><pub-id pub-id-type="doi">10.1093/nar/20.5.1083</pub-id><?supplied-pmid 1549470?><pub-id pub-id-type="pmid">1549470</pub-id></element-citation></ref><ref id="B119-marinedrugs-20-00341"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shizuya</surname><given-names>H.</given-names></name>
<name><surname>Kouros-Mehr</surname><given-names>H.</given-names></name>
</person-group><article-title>The development and applications of the bacterial artificial chromosome cloning system</article-title><source>Keio J. Med.</source><year>2001</year><volume>50</volume><fpage>26</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.2302/kjm.50.26</pub-id><?supplied-pmid 11296661?><pub-id pub-id-type="pmid">11296661</pub-id></element-citation></ref><ref id="B120-marinedrugs-20-00341"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bryksin</surname><given-names>A.V.</given-names></name>
<name><surname>Matsumura</surname><given-names>I.</given-names></name>
</person-group><article-title>Overlap extension PCR cloning: A simple and reliable way to create recombinant plasmids</article-title><source>Biotechniques</source><year>2010</year><volume>48</volume><fpage>463</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.2144/000113418</pub-id><pub-id pub-id-type="pmid">20569222</pub-id></element-citation></ref><ref id="B121-marinedrugs-20-00341"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gibson</surname><given-names>D.</given-names></name>
<name><surname>Young</surname><given-names>L.</given-names></name>
<name><surname>Chuang</surname><given-names>R.</given-names></name>
<name><surname>Venter</surname><given-names>J.</given-names></name>
<name><surname>Hutchison</surname><given-names>C.</given-names></name>
<name><surname>Smith</surname><given-names>H.</given-names></name>
</person-group><article-title>Integration of PCR fragments at any specific site within cloning vectors without the use of restriction enzymes and DNA ligase</article-title><source>Nat. Methods</source><year>2009</year><volume>6</volume><fpage>343</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1318</pub-id><pub-id pub-id-type="pmid">19363495</pub-id></element-citation></ref><ref id="B122-marinedrugs-20-00341"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>Zheng</surname><given-names>G.</given-names></name>
<name><surname>Lu</surname><given-names>Y.</given-names></name>
</person-group><article-title>Recent Advances in Strategies for the Cloning of Natural Product Biosynthetic Gene Clusters</article-title><source>Front Bioeng. Biotechnol.</source><year>2021</year><volume>9</volume><fpage>692797</fpage><pub-id pub-id-type="doi">10.3389/fbioe.2021.692797</pub-id><pub-id pub-id-type="pmid">34327194</pub-id></element-citation></ref><ref id="B123-marinedrugs-20-00341"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clevenger</surname><given-names>K.D.</given-names></name>
<name><surname>Bok</surname><given-names>J.W.</given-names></name>
<name><surname>Ye</surname><given-names>R.</given-names></name>
<name><surname>Miley</surname><given-names>G.P.</given-names></name>
<name><surname>Verdan</surname><given-names>M.H.</given-names></name>
<name><surname>Velk</surname><given-names>T.</given-names></name>
<name><surname>Chen</surname><given-names>C.</given-names></name>
<name><surname>Yang</surname><given-names>K.</given-names></name>
<name><surname>Robey</surname><given-names>M.T.</given-names></name>
<name><surname>Gao</surname><given-names>P.</given-names></name>
</person-group><article-title>A scalable platform to identify fungal secondary metabolites and their gene clusters</article-title><source>Nat. Chem. Biol.</source><year>2017</year><volume>13</volume><fpage>895</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2408</pub-id><pub-id pub-id-type="pmid">28604695</pub-id></element-citation></ref><ref id="B124-marinedrugs-20-00341"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nielsen</surname><given-names>J.</given-names></name>
<name><surname>Keasling</surname><given-names>J.D.</given-names></name>
</person-group><article-title>Engineering cellular metabolism</article-title><source>Cell</source><year>2016</year><volume>164</volume><fpage>1185</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.02.004</pub-id><pub-id pub-id-type="pmid">26967285</pub-id></element-citation></ref><ref id="B125-marinedrugs-20-00341"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ran</surname><given-names>F.</given-names></name>
<name><surname>Hsu</surname><given-names>P.D.</given-names></name>
<name><surname>Wright</surname><given-names>J.</given-names></name>
<name><surname>Agarwala</surname><given-names>V.</given-names></name>
<name><surname>Scott</surname><given-names>D.A.</given-names></name>
<name><surname>Zhang</surname><given-names>F.</given-names></name>
</person-group><article-title>Genome engineering using the CRISPR-Cas9 system</article-title><source>Nat. Protoc.</source><year>2013</year><volume>8</volume><fpage>2281</fpage><lpage>2308</lpage><pub-id pub-id-type="doi">10.1038/nprot.2013.143</pub-id><pub-id pub-id-type="pmid">24157548</pub-id></element-citation></ref><ref id="B126-marinedrugs-20-00341"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>M.M.</given-names></name>
<name><surname>Wong</surname><given-names>F.T.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Luo</surname><given-names>S.</given-names></name>
<name><surname>Lim</surname><given-names>Y.H.</given-names></name>
<name><surname>Heng</surname><given-names>E.</given-names></name>
<name><surname>Yeo</surname><given-names>W.L.</given-names></name>
<name><surname>Cobb</surname><given-names>R.E.</given-names></name>
<name><surname>Enghiad</surname><given-names>B.</given-names></name>
<name><surname>Ang</surname><given-names>E.L.</given-names></name>
<etal/>
</person-group><article-title>CRISPR-Cas9 strategy for activation of silent Streptomyces biosynthetic gene clusters</article-title><source>Nat. Chem. Biol.</source><year>2017</year><volume>13</volume><fpage>607</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2341</pub-id><?supplied-pmid 28398287?><pub-id pub-id-type="pmid">28398287</pub-id></element-citation></ref><ref id="B127-marinedrugs-20-00341"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Behler</surname><given-names>J.</given-names></name>
<name><surname>Vijay</surname><given-names>D.</given-names></name>
<name><surname>Hess</surname><given-names>W.R.</given-names></name>
<name><surname>Akhtar</surname><given-names>M.K.</given-names></name>
</person-group><article-title>CRISPR-based technologies for metabolic engineering in cyanobacteria</article-title><source>Trends Biotechnol.</source><year>2018</year><volume>36</volume><fpage>996</fpage><lpage>1010</lpage><pub-id pub-id-type="doi">10.1016/j.tibtech.2018.05.011</pub-id><?supplied-pmid 29937051?><pub-id pub-id-type="pmid">29937051</pub-id></element-citation></ref><ref id="B128-marinedrugs-20-00341"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boch</surname><given-names>J.</given-names></name>
<name><surname>Scholze</surname><given-names>H.</given-names></name>
<name><surname>Schornack</surname><given-names>S.</given-names></name>
<name><surname>Landgraf</surname><given-names>A.</given-names></name>
<name><surname>Hahn</surname><given-names>S.</given-names></name>
<name><surname>Kay</surname><given-names>S.</given-names></name>
<name><surname>Lahaye</surname><given-names>T.</given-names></name>
<name><surname>Nickstadt</surname><given-names>A.</given-names></name>
<name><surname>Bonas</surname><given-names>U.</given-names></name>
</person-group><article-title>Breaking the code of DNA binding specificity of TAL-type III effectors</article-title><source>Science</source><year>2009</year><volume>326</volume><fpage>1509</fpage><lpage>1512</lpage><pub-id pub-id-type="doi">10.1126/science.1178811</pub-id><?supplied-pmid 19933107?><pub-id pub-id-type="pmid">19933107</pub-id></element-citation></ref><ref id="B129-marinedrugs-20-00341"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Serif</surname><given-names>M.</given-names></name>
<name><surname>Lepetit</surname><given-names>B.</given-names></name>
<name><surname>Wei&#x000df;ert</surname><given-names>K.</given-names></name>
<name><surname>Kroth</surname><given-names>P.G.</given-names></name>
<name><surname>Rio Bartulos</surname><given-names>C.</given-names></name>
</person-group><article-title>A fast and reliable strategy to generate TALEN-mediated gene knockouts in the diatom <italic toggle="yes">Phaeodactylum tricornutum</italic></article-title><source>Algal Res.</source><year>2017</year><volume>23</volume><fpage>186</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.algal.2017.02.005</pub-id></element-citation></ref><ref id="B130-marinedrugs-20-00341"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shang</surname><given-names>J.</given-names></name>
<name><surname>Hu</surname><given-names>B.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Zhu</surname><given-names>F.</given-names></name>
<name><surname>Kang</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>D.</given-names></name>
<name><surname>Sun</surname><given-names>H.</given-names></name>
<name><surname>Kong</surname><given-names>D.-X.</given-names></name>
<name><surname>Hou</surname><given-names>T.</given-names></name>
</person-group><article-title>Cheminformatic insight into the differences between terrestrial and marine originated natural products</article-title><source>J. Chem. Inf. Model.</source><year>2018</year><volume>58</volume><fpage>1182</fpage><lpage>1193</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.8b00125</pub-id><pub-id pub-id-type="pmid">29792805</pub-id></element-citation></ref><ref id="B131-marinedrugs-20-00341"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sedeek</surname><given-names>A.M.</given-names></name>
<name><surname>Ismail</surname><given-names>M.M.</given-names></name>
<name><surname>Elsayed</surname><given-names>T.R.</given-names></name>
<name><surname>Ramadan</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Recent methods for discovering novel bioactive metabolites, specifically antimicrobial agents, from marine-associated microorganisms</article-title><source>Lett. Appl. Microbiol.</source><year>2022</year><pub-id pub-id-type="doi">10.1111/lam.13728</pub-id></element-citation></ref><ref id="B132-marinedrugs-20-00341"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mohamed</surname><given-names>S.S.</given-names></name>
<name><surname>Abdelhamid</surname><given-names>S.A.</given-names></name>
<name><surname>Ali</surname><given-names>R.H.</given-names></name>
</person-group><article-title>Isolation and identification of marine microbial products</article-title><source>J. Genet. Eng. Biotechnol.</source><year>2021</year><volume>19</volume><fpage>162</fpage><pub-id pub-id-type="doi">10.1186/s43141-021-00259-3</pub-id><pub-id pub-id-type="pmid">34665351</pub-id></element-citation></ref><ref id="B133-marinedrugs-20-00341"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baral</surname><given-names>B.</given-names></name>
<name><surname>Akhgari</surname><given-names>A.</given-names></name>
<name><surname>Mets&#x000e4;-Ketel&#x000e4;</surname><given-names>M.</given-names></name>
</person-group><article-title>Activation of microbial secondary metabolic pathways: Avenues and challenges</article-title><source>Synth. Syst. Biotechnol.</source><year>2018</year><volume>3</volume><fpage>163</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/j.synbio.2018.09.001</pub-id><pub-id pub-id-type="pmid">30345402</pub-id></element-citation></ref><ref id="B134-marinedrugs-20-00341"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clardy</surname><given-names>J.</given-names></name>
<name><surname>Fischbach</surname><given-names>M.A.</given-names></name>
<name><surname>Walsh</surname><given-names>C.T.</given-names></name>
</person-group><article-title>New antibiotics from bacterial natural products</article-title><source>Nat. Biotechnol.</source><year>2006</year><volume>24</volume><fpage>1541</fpage><lpage>1550</lpage><pub-id pub-id-type="doi">10.1038/nbt1266</pub-id><pub-id pub-id-type="pmid">17160060</pub-id></element-citation></ref><ref id="B135-marinedrugs-20-00341"><label>135.</label><element-citation publication-type="webpage"><person-group person-group-type="author">
<name><surname>Severino</surname><given-names>A.</given-names></name>
<name><surname>Coppola</surname><given-names>A.</given-names></name>
<name><surname>Correggia</surname><given-names>M.</given-names></name>
<name><surname>Vetriani</surname><given-names>C.</given-names></name>
<name><surname>Giovannelli</surname><given-names>D.</given-names></name>
<name><surname>Cordone</surname><given-names>A.</given-names></name>
</person-group><article-title>From Sequences to Enzymes: Heterologous Expression of Genes from Marine Microbes</article-title><year>2021</year><comment>Available online: <ext-link xlink:href="https://osf.io/6c4su" ext-link-type="uri">https://osf.io/6c4su</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2022-04-19">(accessed on 19 April 2022)</date-in-citation><pub-id pub-id-type="doi">10.31219/osf.io/6c4su</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="marinedrugs-20-00341-f001"><label>Figure 1</label><caption><p>The main procedures of utilizing metagenomics in producing MNPs. Researchers first isolate metagenomic DNA from environmental samples. Then, a metagenomic library constituted by multiple cloning vectors is constructed to carry the isolated DNA, and the vectors are transferred into the host strains to express certain genes. Two strategies are used to search for genes encoding MNPs with bioactivity. A sequence-based strategy uses next-generation sequencing technology to search for homologous sequences of conserved biosynthetic genes in DNA pools, which has great advantages in mining well-studied gene classes from metagenomic DNA. A function-based strategy primarily identifies phenotypic traits of DNA library clones and screen for enzymatic activity or other products with bioactivity.</p></caption><graphic xlink:href="marinedrugs-20-00341-g001" position="float"/></fig><fig position="float" id="marinedrugs-20-00341-f002"><label>Figure 2</label><caption><p>The machinery of two most frequently used in vivo BGC cloning methods (<bold>a</bold>,<bold>b</bold>) and two in vitro DNA assembly methods with complex principals (<bold>c</bold>,<bold>d</bold>). (<bold>a</bold>) Homologous recombination in yeast; (<bold>b</bold>) phage <inline-formula><mml:math id="mm1" overflow="scroll"><mml:mrow><mml:mi>&#x003bb;</mml:mi></mml:mrow></mml:math></inline-formula> recombination; (<bold>c</bold>) overlap extension PCR method; (<bold>d</bold>) Gibson assembly. (<bold>a</bold>,<bold>b</bold>) are in vivo cloning methods that exploit the natural capability of DNA recombination in yeast and phage. (<bold>c</bold>,<bold>d</bold>) are in vitro cloning methods that rely on primers or exonucleases.</p></caption><graphic xlink:href="marinedrugs-20-00341-g002a" position="float"/><graphic xlink:href="marinedrugs-20-00341-g002b" position="float"/></fig><table-wrap position="float" id="marinedrugs-20-00341-t001"><object-id pub-id-type="pii">marinedrugs-20-00341-t001_Table 1</object-id><label>Table 1</label><caption><p>Examples of biosynthesis of MNPs in heterologous hosts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Heterologous Host</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Natural Product</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MNP Type</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BGC Source</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Titer</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Refs</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Gram-positive bacteria</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Streptomyces venezuelae</italic> DHS 2001</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4-<italic toggle="yes">O</italic>-demethylbarbamide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fatty amide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Moorena producens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;1 &#x003bc;g/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B41-marinedrugs-20-00341" ref-type="bibr">41</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. venezuelae</italic> JND2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marineosin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alkaloid</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Streptomyces</italic> sp. CNQ-617</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B42-marinedrugs-20-00341" ref-type="bibr">42</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Streptomyces coelicolor</italic> M1152</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Indolocarbazole alkaloids</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alkaloid</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Streptomyces sanyensis</italic> FMA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B43-marinedrugs-20-00341" ref-type="bibr">43</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> M1152</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kendomycin B</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyketide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Verrucosispora</italic> sp. SCSIO 07399</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B44-marinedrugs-20-00341" ref-type="bibr">44</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> M1152</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RES-701-3, -4</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lasso peptides</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Streptomyces caniferus CA-271066</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B45-marinedrugs-20-00341" ref-type="bibr">45</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> M1154</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lobophorins</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Macrolides</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Streptomyces pactum</italic> SCSIO 02999</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B46-marinedrugs-20-00341" ref-type="bibr">46</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> M1146<break/><italic toggle="yes">Streptomyces</italic>
<italic toggle="yes">lividans</italic> TK23</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enterocin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyketide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Salinispora pacifica</italic> CNT-150</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B47-marinedrugs-20-00341" ref-type="bibr">47</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> M1146</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Taromycin A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lipopeptide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Saccharomonospora</italic> sp. CNQ-490</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-marinedrugs-20-00341" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> M1146</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Streptophenazines</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pyrazines</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Streptomyces sp.</italic> CNB-091</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">over 5 mg/6 L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B49-marinedrugs-20-00341" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> YF11</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluostatin L<break/>Difluostatin A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aromatic polyketides</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Micromonospora rosaria</italic> SCSIO N160</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B50-marinedrugs-20-00341" ref-type="bibr">50</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Streptomyces albus</italic> De114</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nybomycin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alkaloid</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. albus</italic> subsp. <italic toggle="yes">chlorinus</italic> NRRL B-24108</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1 mg/30 mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B51-marinedrugs-20-00341" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. albus</italic> De114</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Albucidin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nucleoside derivative</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. albus</italic> subsp. <italic toggle="yes">chlorinus</italic> NRRL B-24108</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4 mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B52-marinedrugs-20-00341" ref-type="bibr">52</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">S. albus</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Napyradiomycins</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpenoids</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Streptomyces sp.</italic> CNQ-525</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B53-marinedrugs-20-00341" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. albus</italic> J1074<break/><italic toggle="yes">S.</italic>
<italic toggle="yes">lividans</italic> TK21</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thiocoraline</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thiodepsipeptide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Micromonospora</italic> sp. ML1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B54-marinedrugs-20-00341" ref-type="bibr">54</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. albus</italic> J1074</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Berninamycins J and K</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thiopeptides</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Streptomyces</italic> sp. SCSIO 11878</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B35-marinedrugs-20-00341" ref-type="bibr">35</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Streptomyces tropica CNB-4401</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thiolactomycin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyketide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Streptomyces. pacifica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3-fold higher</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B55-marinedrugs-20-00341" ref-type="bibr">55</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Bacillus subtilis</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preamicoumacins</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isocoumarin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Bacillus subtilis 1779</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B56-marinedrugs-20-00341" ref-type="bibr">56</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Gram-negative bacteria</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Anabaena</italic> sp. PCC 7120</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cryptomaldamide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hybrid tripeptide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Moorena producens</italic> JHB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-formula><mml:math id="mm2" overflow="scroll"><mml:mrow><mml:mn>25.9</mml:mn><mml:mtext>&#x000a0;</mml:mtext><mml:mo>&#x000b1;</mml:mo></mml:mrow></mml:math></inline-formula>3.6 mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B57-marinedrugs-20-00341" ref-type="bibr">57</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Anabaena</italic> sp. PCC 7120</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lyngbyatoxin A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpenoid indole alkaloid</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Moorena producens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.2 mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B58-marinedrugs-20-00341" ref-type="bibr">58</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Anabaena</italic> sp. PCC 7120</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pendolmycin </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Indolactam alkaloid</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Marinactinospora thermotolerans</italic> SCSIO 00652</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B59-marinedrugs-20-00341" ref-type="bibr">59</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Anabaena</italic> sp. PCC 7120</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Teleocidin B-4</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Indolactam alkaloid</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Streptomyces blastmyceticus</italic> NBRC 12747</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B59-marinedrugs-20-00341" ref-type="bibr">59</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Escherichia coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patellamides A and C</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyclic peptides</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Prochloron</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B60-marinedrugs-20-00341" ref-type="bibr">60</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xylanase</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Marinimicrobium</italic> sp. LS-A18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B61-marinedrugs-20-00341" ref-type="bibr">61</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-amylase</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Zunongwangia profunda</italic> (MCCC 1A01486)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B62-marinedrugs-20-00341" ref-type="bibr">62</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kappa -Carrageenase</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Zobellia</italic> sp. ZM-2.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9-fold higher</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B63-marinedrugs-20-00341" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chitinase <italic toggle="yes">Pt</italic>Chi19p</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Pseudoalteromonas tunicata</italic> CCUG 44952T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B64-marinedrugs-20-00341" ref-type="bibr">64</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lyngbyatoxin A<break/>Indolactam-V</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Indole alkaloids</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Moorena producens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.6 mg/L<break/>150 mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B65-marinedrugs-20-00341" ref-type="bibr">65</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Surfactant</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lipopeptide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Bacillus licheniformis</italic> NIOT-06</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-marinedrugs-20-00341" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alginate lyase</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Vibrio</italic> sp. QY102</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.58 g/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B67-marinedrugs-20-00341" ref-type="bibr">67</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alterochromide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lipopeptide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Pseudoalteromonas piscicida</italic> JCM 20779</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B68-marinedrugs-20-00341" ref-type="bibr">68</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic> BL<sub>21</sub>(DE<sub>3</sub>)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thalassomonasins A and B</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lanthipeptides</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Thalassomonas actiniarum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.9 mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B69-marinedrugs-20-00341" ref-type="bibr">69</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic> BL<sub>21</sub>(DE<sub>3</sub>)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marinomonasin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tricyclic peptide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Marinomonas fungiae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B70-marinedrugs-20-00341" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic> BL<sub>21</sub>(DE<sub>3</sub>)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alkaline lipase</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marine sponge metagenome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B71-marinedrugs-20-00341" ref-type="bibr">71</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic> BL<sub>21</sub>(DE<sub>3</sub>)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifungal peptide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peptide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Seawater metagenome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B72-marinedrugs-20-00341" ref-type="bibr">72</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vibrioferrin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tricarboxylic acid</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tidal-flat sediment metagenome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">92.6 mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-marinedrugs-20-00341" ref-type="bibr">27</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Avaroferrin<break/>Putrebactin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alkaloids</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deep-sea metagenome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.5 mg/L<break/>1.2 mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B73-marinedrugs-20-00341" ref-type="bibr">73</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bisucaberin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydroxamate</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deep-sea metagenome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.4 mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B74-marinedrugs-20-00341" ref-type="bibr">74</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lipase</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marine sponge metagenome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B75-marinedrugs-20-00341" ref-type="bibr">75</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Halichrome A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biindole</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marine sponge metagenome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B76-marinedrugs-20-00341" ref-type="bibr">76</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Esterase</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marine mud metagenome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-marinedrugs-20-00341" ref-type="bibr">77</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chitosanase</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marine mud metagenome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B78-marinedrugs-20-00341" ref-type="bibr">78</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Laccase</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marine microbial metagenome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B79-marinedrugs-20-00341" ref-type="bibr">79</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Desferrioxamine E<break/>Desferrioxamine D2<break/>Desferrioxamine X1<break/>Desferrioxamine X2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Siderophores</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fusion of marine metegenomic DNA and a terreastial bacterium</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27 mg/L<break/>53 mg/L<break/>7.1 mg/L<break/>1.2 mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B80-marinedrugs-20-00341" ref-type="bibr">80</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Myxococcus xanthus</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Haliangicin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyketide</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Haliangium ochraceum</italic> SMP-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10-fold higher</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B81-marinedrugs-20-00341" ref-type="bibr">81</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Fungi</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus nidulans</italic> RJMP1.59</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Beauvericin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyclic lipopeptides</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Fusarium proliferatum</italic> LF061</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">668.97 mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-marinedrugs-20-00341" ref-type="bibr">82</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Microalgae</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fistulifera solaris</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prostaglandins</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fatty acids</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Agarophyton vermiculophyllum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1290.4 ng/g<break/>cell dry weight</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-marinedrugs-20-00341" ref-type="bibr">83</xref>]</td></tr></tbody></table></table-wrap><table-wrap position="float" id="marinedrugs-20-00341-t002"><object-id pub-id-type="pii">marinedrugs-20-00341-t002_Table 2</object-id><label>Table 2</label><caption><p>Summary of BGC cloning methods applied in the heterologous expression of MNP BGCs.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BGC Cloning<break/>Methods</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Advantages</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Disadvantages</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Refs</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">in vivo</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TAR</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directly clone MNP BGCs up to 300 kb</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">False positives</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B45-marinedrugs-20-00341" ref-type="bibr">45</xref>,<xref rid="B47-marinedrugs-20-00341" ref-type="bibr">47</xref>,<xref rid="B48-marinedrugs-20-00341" ref-type="bibr">48</xref>,<xref rid="B49-marinedrugs-20-00341" ref-type="bibr">49</xref>,<xref rid="B56-marinedrugs-20-00341" ref-type="bibr">56</xref>,<xref rid="B57-marinedrugs-20-00341" ref-type="bibr">57</xref>,<xref rid="B58-marinedrugs-20-00341" ref-type="bibr">58</xref>,<xref rid="B68-marinedrugs-20-00341" ref-type="bibr">68</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003bb;/Red</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Direct modification of DNA within <italic toggle="yes">E. coli</italic> and this method is independent of restriction sites</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The efficiency drops sharply as the size of the cassette increases.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B43-marinedrugs-20-00341" ref-type="bibr">43</xref>,<xref rid="B48-marinedrugs-20-00341" ref-type="bibr">48</xref>,<xref rid="B59-marinedrugs-20-00341" ref-type="bibr">59</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Red/ET</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A powerful tool for DNA subcloning and DNA modifications</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hard to mediate homologous recombination between two linear DNA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B41-marinedrugs-20-00341" ref-type="bibr">41</xref>,<xref rid="B42-marinedrugs-20-00341" ref-type="bibr">42</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SIRA</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Efficient genomic assembly of large MNP BGCs (&#x0003e;100 kb)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Requirement of specific sites integrated into the chromosome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-marinedrugs-20-00341" ref-type="bibr">48</xref>,<xref rid="B55-marinedrugs-20-00341" ref-type="bibr">55</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">in vitro</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cosmid library</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Simple construction of cosmid library</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tedious screening</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B35-marinedrugs-20-00341" ref-type="bibr">35</xref>,<xref rid="B43-marinedrugs-20-00341" ref-type="bibr">43</xref>,<xref rid="B50-marinedrugs-20-00341" ref-type="bibr">50</xref>,<xref rid="B53-marinedrugs-20-00341" ref-type="bibr">53</xref>,<xref rid="B54-marinedrugs-20-00341" ref-type="bibr">54</xref>,<xref rid="B81-marinedrugs-20-00341" ref-type="bibr">81</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fosmid library</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">More stable than the conventional cosmids; allows for both low/single copy number and high copy propagation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A fosmid vector only accepts small BGCs (up to 45 kb).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-marinedrugs-20-00341" ref-type="bibr">27</xref>,<xref rid="B60-marinedrugs-20-00341" ref-type="bibr">60</xref>,<xref rid="B65-marinedrugs-20-00341" ref-type="bibr">65</xref>,<xref rid="B73-marinedrugs-20-00341" ref-type="bibr">73</xref>,<xref rid="B74-marinedrugs-20-00341" ref-type="bibr">74</xref>,<xref rid="B75-marinedrugs-20-00341" ref-type="bibr">75</xref>,<xref rid="B76-marinedrugs-20-00341" ref-type="bibr">76</xref>,<xref rid="B77-marinedrugs-20-00341" ref-type="bibr">77</xref>,<xref rid="B78-marinedrugs-20-00341" ref-type="bibr">78</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Restriction enzyme-mediated</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High efficiency; simple operation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Strict limitations on the restriction sites in the target sequences</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B61-marinedrugs-20-00341" ref-type="bibr">61</xref>,<xref rid="B62-marinedrugs-20-00341" ref-type="bibr">62</xref>,<xref rid="B63-marinedrugs-20-00341" ref-type="bibr">63</xref>,<xref rid="B67-marinedrugs-20-00341" ref-type="bibr">67</xref>,<xref rid="B69-marinedrugs-20-00341" ref-type="bibr">69</xref>,<xref rid="B70-marinedrugs-20-00341" ref-type="bibr">70</xref>,<xref rid="B71-marinedrugs-20-00341" ref-type="bibr">71</xref>,<xref rid="B72-marinedrugs-20-00341" ref-type="bibr">72</xref>,<xref rid="B79-marinedrugs-20-00341" ref-type="bibr">79</xref>,<xref rid="B80-marinedrugs-20-00341" ref-type="bibr">80</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BAC</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clone large-sized DNA fragments from the complex genome</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tedious screening</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B44-marinedrugs-20-00341" ref-type="bibr">44</xref>,<xref rid="B46-marinedrugs-20-00341" ref-type="bibr">46</xref>,<xref rid="B51-marinedrugs-20-00341" ref-type="bibr">51</xref>,<xref rid="B52-marinedrugs-20-00341" ref-type="bibr">52</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Overlap extension PCR</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No need for restriction endonucleases or T4 DNA ligase</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Possibility of introducing mutations</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B45-marinedrugs-20-00341" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gibson assembly</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No concerns for internal restriction enzyme cutting sites</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not applicable for the DNA fragments with high GC content (over 60%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-marinedrugs-20-00341" ref-type="bibr">82</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>TAR, transformation-associated recombination; SIRA, serine integrase recombination assembly; BAC, bacterial artificial chromosome.</p></fn></table-wrap-foot></table-wrap></floats-group></article>